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ABSTRACT 
 
Neutrophil extracellular traps (NETs) are composed of a backbone of chromatin, decorated 
with microbicidal peptides and proteolytic enzymes, and are used by neutrophils as a weapon 
against pathogens. Since their initial discovery in 2004, NETs have challenged scientists in 
terms of the nature of the triggers and the mechanisms of neutrophil release of NETs, as well 
as the implication of these extracellular structures in infectious and non-infectious human 
diseases. The work presented in this thesis, performed in an interdisciplinary perspective using 
an array of different methodologies, aims to deepen the knowledge on the functionality and 
dysfunctionality of NETs, including the mechanism of NET disposal and its immunological 
consequences. Once NETs have fulfilled their anti-microbial function, the timely clearance of 
these structures is needed in order to avoid a misguided autoinflammatory response. In Paper I, 
we showed that primary human macrophages employ TREX1, while dendritic cells use 
DNase1L3 to digest NETs purified from activated neutrophils. In addition, on the basis of 
cytokine profiling, we showed that NETs have immunomodulatory effects on phagocytes. In 
Paper II, we showed that JAGN1 is required for efficient fungal killing in NETs. Patients 
suffering from severe congenital neutropenia (SCN) present homozygous mutations in the gene 
encoding JAGN1 and are susceptible to bacterial and fungal infections. We found that 
JAGN1-deficient neutrophils isolated from an SCN patient, as well as neutrophil-like HL-60 
cells with silenced JAGN1 expression, released NETs, but the expression of myeloperoxidase 
(MPO) was altered. In Paper III and IV we explored the interactions of NETs with graphene 
oxide (GO), a carbon-based 2-D material. Using ToF-SIMS, a mass spectrometry-based 
surface analytical method, we could show in Paper III that GO interacts with the plasma 
membrane of neutrophils, promoting cholesterol oxidation. In addition, we could define a 
size-dependent mechanism of GO induced release of NETs. Furthermore, we showed in 
Paper IV that GO undergoes efficient extracellular degradation through neutrophil 
degranulation or in NETs in a process dependent on MPO. Moreover, intermediate degradation 
products of GO did not cause DNA damage in lung cells. Overall, the work presented in this 
thesis has shed light on the clearance and degradation of NETs by phagocytic cells and the 
involvement of several endonucleases in a cell type-specific manner, and has confirmed the 
importance of NETs in fungal killing, with new evidence for a role of JAGN1 in this process. 
In addition, we have shown for the first time that GO triggers NETs and reported that GO may 
also undergo degradation in NETs in a similar manner as pathogens. Our studies have thus 
revealed that MPO expressed in NETs is a key element in eliminating infectious as well as non-
infectious agents.   
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1 INTRODUCTION 
1.1 INFLAMMATION 
The classical definition of inflammation, compiled by Celsus and Galen, delineates the 
phenomoenon as the manifestation of pain (dolor), warmth (calor), swelling (tumor), redness 
(rubor) and ultimately loss of function (functio laesa). Nowadays, inflammation is generally 
described as a physiological response to pathogen infections or insults that perturb the 
organism´s homeostasis. The aim of an inflammatory response is to exclude or eliminate the 
source of injury while temporarily adapting to the atypical condition and to ultimately restore 
functionality and homeostasis in the tissue (Medzhitov, 2008). Inflammation can likewise 
occur when the integrity of the organism is lost, as in necrotic cell death, without the action of 
external pathogens, and is therefore named “sterile inflammation” (Kono et al. 2014). Due to 
the multifaceted panel of responses that occur during the inflammatory process, such as the 
release of an heterogeneicity of soluble mediators and complement activation, which can be 
tissue-specific and cause-related, an univocal definition of inflammation might result reductive 
and unappropriate (Netea et al. 2017). It is therefore important to consider both the basic 
mechanisms and key players of this phenomenon in light of its complexity, trying to understand 
“the bigger picture” rather than focusing on individual aspects. 
1.1.1 Key players in inflammation 
The inflammatory process requires the coordination of the interplay between several actors, 
which can be classified in three main categories: inflammation inducers and related sensors, 
mediators of inflammations and effectors (Medzhitov, 2008). Inflammation inducers are 
molecules either of exogenous origin or that can arise from the organism itself in situation of 
stress, malfunction or damage of the tissues. Pathogen-associated molecular patterns (PAMPs) 
are of non-self origin and are highly conserved domains of peculiar structures commonly 
occurring among pathogens, while self molecules, that do not generally present an hazard due 
to their compartmentalization in intact cells or that are modified in the stressed 
microenvironment, are defined as DAMPs (Medzhitov, 2008). With the advent of 
nanotechnology, interactions between engineered nano-scaled entities and the immune system 
started to be investigated. It should not surprise that engineered nanomaterials introduced in 
biological systems could be perceived as non-self entities or, after absorption and modification 
of biomolecules on their surface, inducing the formation of complexes containing “altered self” 
epitopes that can be sensed by the innate immune system. In this context, nanomaterial-based 
inflammation inducers have been defined as nanoparticle-associated molecular patterns, or 
NAMPs (Fadeel, 2012 and Farrera and Fadeel, 2015). A panel of receptors, so-called pattern 
recognition receptors (PPRs), senses the danger signals and modulates the production of 
soluble mediators, which in turn activate effector target cells in different tissues. The ultimate 
goal of soluble mediators is to modulate the status of targeted cells in order to transiently adapt 
it to the harmful condition and, eventually, tune it to restore tissue homeostasis 
(Medzhitov, 2008 and Netea et al. 2017). 
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1.1.2 Role in disease 
Acute inflammation responses are displayed from the first moments after pathogen invasion or 
tissue damage and rely on the autocrine and paracrine effects of the soluble mediators, 
primarily cytokines as TNFα and IL-1β, and chemokines as IL-8. The pro-inflammatory milieu 
typical of the first phases of inflammation should be timely restricted in order to avoid tissue 
damage caused by the immune system itself. Resolution of inflammation, intended as the 
removal of the cause, as well as reestablishment of physiological homeostasis in the tissue, is 
a mechanism based on active reprogramming of immune-competent cells. This is achieved 
through a different panel of cytokines aimed to reprogram macrophages, through the depletion 
of chemokines and the clearance of apoptotic cells from the site of infection (Ortega-Gomez et 
al. 2013 and Sugimoto et al. 2016). When sustainment of the abnormal microenvironment is 
not transient, the affected tissue is pushed to adapt to a chronic inflammatory status, which is a 
hallmark of several diseases. 
 
One of the prevailing chronic inflammatory diseases, with an incidence up to 1% of the 
population, is rheumatoid arthritis (RA). Chronic inflammation in RA mainly affects the 
synovial membrane in the joints, where massive infiltration of innate and adaptive immune 
cells occurs in response to a microenvironment rich in cytokines and chemokines, among which 
TNFα, IL-6 and GM-CSF are mayhap the most relevant (Smolen et al. 2016). The chronic 
inflammation is the result of an autoimmune response to citrullinated epitopes leading to the 
rise of anti-citrullinated protein antibodies (ACPAs) that can form immunocomplexes and 
activate the complement system. The sustained inflammatory milieu in the joints ultimately 
results in reprogramming chondrocytes and osteoclasts towards catabolism of the tissue 
(Smolen et al. 2016).  
 
Another example is systemic lupus erythematosus (SLE), a systemic autoimmune disease that 
targets different organs and increases the mortality risk of the patients, in prevalence women, 
compared to the general population (Kaul et al. 2016). SLE patients suffer from chronic 
inflammation at skin, blood vessels and kidney level due to the overproduction of 
anti-neutrophil cytoplasmic antibodies (ANCAs) that form immunocomplexes deposited either 
in situ or in the kidneys, determining kidney failure in the worst cases. Current treatments for 
SLE include NSAIDs and corticosteroids; biological treatments aim to deplete or modulate B 
cells and T cells populations as well as target pro-inflammatory cytokines (TNFα, type I 
interferons) (Lisnevskaia et al. 2014). The nature of SLE is multifactorial, displaying disorders 
in both innate and adaptive immunity. T follicular helper cells from SLE patients are more 
prone to activate IgG production by B cells in response to auto antigens, and it has been 
reported that regulatory T cells display reduced number or function in SLE patients, thus 
impairing the ability to suppress T helper cells proliferation (Rahman and Isenberg, 2008).  
1.2 INNATE IMMUNE SYSTEM 
The innate immune system is the first line of defense that organisms use to counteract invading 
pathogens and its basic mechanisms are evolutionary conserved from plants to vertebrates. 
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Unlike the other branch of the immune system, innate immunity relies on a rather unspecific 
type of response, which is functional to a swift reaction and a broad-spectrum efficacy, 
orchestrated by a cellular component and a humoral component (Turvey and Broide, 2010). 
 
Within the humoral section of the innate immune system, which includes proteins and peptides 
constitutively present in the serum or secreted ad hoc, a further subdivision can be done 
discriminating between the complement system and antimicrobial peptides (Beutler, 2004). 
Antimicrobial peptides (AMPs) are evolutionary conserved structures which, in mammals, are 
primarily present in neutrophilic granules and epithelial cells, consisting in general of up to 50 
aminoacids. In several cases, they originate from an inactive precursor via proteolitic cleavage, 
and are released upon necessity, allowing for a multi-level controlled regulation of their activity 
(Mahlapuu et al. 2016). In humans, several classes of AMPs are present, however, the 
cathelicidin-derived LL-37 peptide has recently gained novel interest, as not only microbicidal 
properties are associated with it, but also immunomodulatory effects. It is not possible to define 
a priori whether LL-37 directs the immune response towards a pro- or an anti-inflammatory 
outcome, as concurrent microenvironmental factors have to be considered, nevertheless its 
effects on type I IFNs production are quite well defined (Khalenberg and Kaplan, 2013). Due 
to its capacity of binding DNA and enhancing its internalization in cells of myeloid origin, 
LL-37 promotes both the intracellular STING-mediated and the TLR 7/9-mediated sensing of 
the nucleic acid, triggering the release of type I IFNs (Chamilos et al. 2012 and Ganguly et al. 
2009). Under the name “complement” falls a network of serum protiens that are sequentially 
activated by proteolitic cleavage, whose critical functions are proinflammatory signaling and 
promotion of phagocytosis (Ricklin et al. 2010). Three distinct patways (classical, alternative, 
lectin) converge in the activation of the C3 component, downstream of which the effector 
molecules are initiated to ultimately enhance phagocytosis and immune responses 
(Hajishengallis et al. 2017). The classical pathway is initiated by IgM or IgG-antigen 
immunocomplexes recognized by C1q, similarly, the lectin pathway relies on the recognition 
of carbohydrate mioeties by mannose-binding lectins and ficolins. The alternative pathway 
exploits a fraction of hydrolized C3 which actively probes cell surfaces and is activated by 
carbohydrate moieties on foreign cells, as well as properdin, as initiator ligands (Ricklin et al. 
2010). 
 
The cellular arm of the innate immune system genereally identifies with cells of hematopoietic 
origin, namely myeloid cells, however, endothelial cells and epithelial cells, for instance, are 
also immuno-competent and should not be disregarded. These different cell types share the 
function of using a panel of sensors developed to recognize similar epitopes on different 
pathogens (PAMPs), or endogenous molecular patterns (DAMPs) which determine a harmful 
signature. These receptors are globally defined as pattern recognition receptors (PRRs) and 
ultimately regulate transcription and processing of cytokines but also cell death, autophagy and 
phagocytosis (Brubaker et al. 2015). PRRs can localize on the plasma membrane or 
intracellularly, either in the cytosol or within membranes of endocytic inclusions. Proper 
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localization and compartimentalization of PRRs is an imprescindible feature in order to avoid  
undesired responses to self molecules (Brubaker et al. 2015).  
 
The Toll-like receptor (TLR) family of PRRs comprises both cytosolic and membrane bound 
members, covering a wide assortment of ligands both from microbial or viral origin and self 
origin. TLR4 recognizes lipopolysaccharide (LPS) in a multi-receptor complex with the aid of 
CD14 and myeloid differentiation factor 2 (MD2), using myeloid differentiation primary 
response 88 (MyD88) to transduce the signal intracellularly promoting transcription of genes 
regulated by nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) (Takeuchi 
and Akira, 2010). A subset of TLRs, namely TLR3, TLR8 (TLR7 in mice) and TLR9, is 
deputed to the recognition of nucleic acids of different fashion and different origin. Signaling 
through these receptors ultimately leads to the production of type I IFNs, a hallmark of 
autoimmune disease as SLE. Compartimentalization of these TLRs, together with degradation 
of self-DNA by intra and extracellular nucleases is aimed to prevent the mounting of an 
autoimmune response to nucleic acids, directing it primarily towards DNA and RNA of 
bacterial or viral origin. Still, complexes of DNA or RNA with proteins or peptides, as LL-37, 
ease internalization of the nucleic acids into the cells, promoting TLR-mediated IFN responses 
(Takeuchi and Akira, 2010). Cytosolic DNA, both viral and self, can also be recognized by 
STING, which localizes at the endoplasmic reticulum membrane, and is able to interact with 
dsDNA directly, or via pre-processing of the nucleic acid by cyclic GMP-AMP synthase 
(cGAS). Although appearing to be independent of other TLR-DNA sensing machineries, 
STING also activates NF-κB dependent production of type I IFNs (Barber, 2015).  
 
While the basic knowledge on the PRRs-PAMPs and PRRs-DMAPs network is already 
established and continues to expand, the pieces of the PRRs-NAMPs puzzle are still waiting to 
be resolved. To date, a large body of studies focuses on the outcomes of the encounter or 
exposure of innate immune cells and engeneered nanomaterials, yet experimental evidence of 
immune cells-mediated sensing of nanoparticles awaits to be expanded.  
1.2.1 Neutrophils 
Among the components of the innate immune system, neutrophils are the first-line defense 
against a wide variety of pathogens, including bacteria and fungi (Mócsai, 2013). 
Neutrophils, also known as polymorphonuclear leukocytes (PMNs), are produced in the bone 
marrow through a process named myelopoiesis. Neutrophils and monocytes share a common 
progenitor stem cell in the bone marrow, then, neutrophils undergo granulocytopoiesis that 
leads to the sequential maturation of granules, namely primary (azurophilic) granules, 
secondary (specific) granules, tertiary (gelatinase) granules and secretory vesicles (Borregaard 
et al. 1995). Granulopoiesis is fine-tuned by granulocyte colony stimulating factor (G-CSF) 
that regulates production of PMNs under physiological conditions or infection (Soehnlein et 
al. 2017). Mature neutrophils are eventually released in the blood stream in a process mediated 
by the CXCR4 receptor, which is essential for retaining the PMNs in the bone marrow 
(Borregaard, 2010). Accounting for the majority of all circulating leukocytes (50-70%) in 
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humans, neutrophils patrol the blood vessels where they can survive up to 12 hours, while in 
tissues site of infection their lifespan is around 1-2 days (Mayades et al. 2014). 
 
A simplistic view of the neutrophil function in the innate immune system has portrayed PMNs 
as “dumb” cells, solely devoted to the disposal of pathogens. In the last decades, the interest in 
neutrophil biology has increased, revealing a more complex and multifaceted role for the 
polymorphonuclear phagocytes (Nathan, 2006). To date, neutrophils are known to mediate the 
immune response via regulation of other innate immune cells, monocyte/macrophages and 
dendritic cells for example (Soehnlein et al. 2017), as well as tuning the adaptive immune 
response via interaction with B cells and T cells (Mócsai, 2013). The cross talk with the other 
cell types of the immune system is bi-directional: PMNs receive signals modulating cell 
survival and effector functions by other cell types, while in turn they initiate, suppress or 
regulate the reaction of innate and adaptive immune cells, either via direct cell-to-cell 
interaction, or soluble mediators as cytokines and chemokines (Scapini and Cassatella, 2014). 
The diversity of neutrophilic functions is correlating with the concept of neutrophil 
heterogeneity, which is becoming of interest in the recent years. As for the other cells of the 
immune system, phenotyping of neutrophils has given information on the presence of different 
subsets of PMNs, putatively programmed to exert or be more proficient for discrete functions. 
Low density granulocytes (LDGs) for instance, named after the fact that they sediment within 
the PBMCs layer after density gradient centrifugation, are found with higher recurrence in 
patients with autoimmune diseases and are prone to employ proinflammatory functions 
(Scapini et al. 2016).  
 
As for the disposal of pathogens, neutrophils can make use of a repertoire of killing strategies: 
phagocytosis, degranulation and release of extracellular traps (Papayannopoulos and 
Zychlinsky, 2009), as represented in Figure 1.  
 
Figure 1. Strategies of pathogen killing operated by neutrophils. Adapted from: Gray et al. 
2015. Antibiotics (Basel). 4: 62-75. 
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The phagocytic process in neutrophils is performed in a timeframe of seconds. The pathogens 
are internalized in phagosomes on whose membrane the NADPH oxidase complex is 
assembled to produce reactive oxygen species (ROS) that are released in the phagosome. The 
phagosome also fuses with the pre-formed cytosolic granules, which in turn discharge their 
pool of antimicrobial peptides and lytic enzymes (Nordenfelt and Tapper, 2011). The content 
of granules can also be released into the extracellular environment upon stimulation in order to 
create an unfavorable milieu for the pathogens. Generally, the content of secretory vesicles and 
tertiary granules is released extracellularly and the fusion of the granule membrane with the 
plasma membrane allows for the exposure of receptors involved in adhesion and chemotaxis 
(Mayades et al. 2014). Antimicrobial cationic peptides are capable of interaction with the 
negatively charged membrane of pathogens perturbing its stability via formation of pores that 
lead to the lysis of the microbes (Mahlapuu et al. 2016). 
1.2.2 Macrophages and Dendritic Cells 
Macrophages are professional phagocytes and they contribute to homeostasis by engulfing not 
only pathogens and toxic molecules, but also apoptotic cells, preventing them to enter 
secondary necrosis, thus playing a pivotal role in management of inflammation (Galli et al. 
2011). The traditional paradigm about macrophages suggests that these cells, deriving from 
circulating monocytes, are recruited at site of infection where they can challenge pathogens 
and participate in the inflammatory responses. Else, tissue resident macrophages are primarily 
involved in resolution of inflammation and maintenance of tissue homeostasis, being replaced 
by monocytic precursors at need. A new body of evidence has started to show that tissue 
macrophages can develop within tissues biogenesis since embryonic development and are 
endowed with self-renewal properties (Italiani and Boraschi, 2014). Moreover, the traditionally 
used nomenclature employed to define different kinds of macrophages, attempting to define 
functions or phenotype, such as M1 versus M2 or alternatively versus classically activated 
macrophages, is based on discrete criteria thus delineating that the use of these terms might be 
misleading and prone to be confounding instead of clarifying. A consensus on nomenclature is 
not yet established, highlighting that an accurate description of the isolation, stimulation and 
analysis methods of macrophages used in each study are demanded in order to allow 
reproducibility, comparability and reliability of the findings (Murray et al. 2014). 
Dendritic cells (DCs) are involved in the recognition and internalization of PAMPs and 
DAMPs (Kono et al. 2014), they can process and present them as antigens to the cells of the 
adaptive immune system that would in turn be activated and, in case of B cells, produce 
antibodies and autoantibodies involved in the onset and exacerbation of autoimmune diseases. 
As for the macrophage constellation, the nomenclature and classification of DCs needs to be 
implemented, especially regarding the human system (Haniffa et al. 2013). 
Besides their prominent role in orchestrating the inflammatory process via the release of 
soluble mediators, macrophages and DCs are key players in keeping and restoring tissue 
homeostasis: phagocytosis of apoptotic cells triggers anti-inflammatory responses, tissue repair 
mechanisms and promotes immunological tolerance (Poon et al. 2014). 
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1.2.3 Soluble mediators 
Cytokines, chemokines and growth factors can be described as soluble mediators, molecules 
that are produced by a cell, released into the extracellular environment and sensed through 
specific receptors on other cells, modifying the status of the latter in order to adapt it to the 
contingent situation. Among the main functions of soluble mediators are hematopoiesis, 
modulation of the inflammatory response and tissue remodelling. Although nomenclature and 
classification of soluble mediators is continuously evolving, some terms are worthy to be 
defined. Interleukins are secreted proteins that act in intercellular communication between 
leukocytes, and they are usually categorized in different families based on similar functionality, 
receptors to which they bind, or structure homology (Akdis et al. 2016). The term chemokine, 
a fusion between the words chemotactic and cytokine, identifies soluble mediators with 
chemotactic activity. Chemokines influence migration of immune cells in both physiological 
conditions (i.e. mobilization of neutrophils from the bone marrow into the blood stream) and 
infection, regulating localization and transmigration between the systemic circulation and the 
affected tissues (Griffith et al. 2014).                                                                       
1.2.4 Defects in the innate immune system: Severe Congenital Neutropenia 
Severe congenital neutropenia (SCN, also known as Kostmann disease) has been first described 
in 1956 by Rolf Kostmann, who identified a recurrent disease phenotype studying the 
population of a geographical isolate in the north of Sweden (Kostmann, 1956). SCN is a life 
threatening autosomal recessive disease characterized by an abnormally low neutrophil count 
in the blood stream, usually less than 200 PMNs / µl of blood (Glaubach et al. 2014). The onset 
of the disease is typically in the first months of life: patients suffer of recurrent infections 
characterized by a decreased formation of pus at sites of infection. The reduced number of 
circulating PMNs in these patients is due to a maturation arrest of the myeloid progenitor cells 
in the bone marrow, between the promyelocyte and myelocyte stage of differentiation. SCN is 
caused by genetic mutations affecting a panel of genes, resulting in the general feature of 
increased apoptosis of the granulocytes. Mutations of the ELANE gene, codifying for 
neutrophil elastase, have been described in more than half of SCN patients. Alterations in the 
ELANE gene, affecting both exons and introns, have been first shown in patients affected by 
cyclic neutropenia (Horwitz et al. 1999), then described in SCN patients who displayed greater 
diversity in the mutation pattern (Dale et al. 2000). Defects in the translation products have 
been shown to lead to misfolded NE rather than loss of function mutants. Misfolded NE 
induced ER stress, reduced clonogenic capacity and triggered apoptosis of the granulocyte 
precursors (Grenda et al. 2007). SCN patients with mutation in the gene codifying for 
HCLS1-associated protein X-1 (HAX1) have also been reported. Affected patients are deficient 
for HAX1 in hematopoietic cells, while in healthy individuals the protein is ubiquitously 
expressed and localizes mainly to mitochondria (Klein et al. 2007). The lack of HAX1 causes 
mitochondrial membrane potential dissipation, resulting in increased cell death, both 
spontaneous and TNF-α induced; the apoptosis-prone phenotype of HAX1 deficient cells could 
be rescued by retroviral gene transfer of a plasmid construct bearing the HAX1 gene in both 
myeloid precursor cells and fibroblasts (Klein et al. 2007). Observations in mice models (Chao 
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et al. 2008), as well as in the original pedigree described by Kostmann, highlighted a link 
between increased apoptosis, due to HAX1 deficiency, and cognitive impairment of various 
level, defining a complex phenotype in HAX1-deficient SCN patients (Carlsson et al. 2008). 
 
In 2014 Botzug et al. described a novel gene implicated in SCN. The group identified nine 
distinct mutations in the Jagunal Homolog 1 (JAGN1) gene, defining an apoptosis-prone 
phenotype in the patients´ PMNs. Described for the first time in Drosophila melanogaster, 
jagunal was shown to be functional to the reorganization of ER during oogenesis, which was 
compromised by its loss (Lee and Cooley, 2007). Neutrophils with mutant JAGN1 displayed 
aberrant ER structure and scarcity of granules as well as impaired glycosylation of multiple 
proteins. The exact function of JAGN1 in humans is still to be investigated, but it appears to 
have a role in ER trafficking (Botzug et al. 2014). Moreover, selective deletion of Jagn1 in 
mice hematopoietic cells led to an impaired killing capacity of neutrophils in Candida albicans 
infections, without affecting their phagocytic capacity or ROS production (Wirnsberger et al. 
2014). MPO levels and ability to release it upon challenge with C. albicans were also impaired 
in Jagn1 deficient neutrophils as well as in PMNs isolated from patients. Notably, 
administration of GM-CSF, but not G-CSF, to JAGN1 mutant PMNs restored their expression 
of MPO as well as killing capacity of C. albicans (Wirnsberger et al. 2014). 
 
The current therapy for SCN patients is administration of recombinant human G-CSF 
(rhG-CSF), which reverses neutropenia, leading to a normal neutrophil count in the blood 
stream. SCN patients bearing ELANE mutations and treated with G-CSF presented neutrophils 
with normal phagocytic capacity but reduced NE and MPO levels, as well as impaired ability 
to control C. albicans infections (Donini et al. 2007). The reduced ability to resolve infections, 
despite the conservation of phagocytic capacity of neutrophils from SCN patients, suggests that 
other mechanisms of pathogen killing could be impaired: for example, NET production could 
be affected as well as NET composition, resulting in higher susceptibility to infection and less 
prompt resolution. 
1.3 NEUTROPHIL EXTRACELLULAR TRAPS (NETs) 
Brinkmann and colleagues reported for the first time the release of neutrophil extracellular traps 
(NETs) as a new killing strategy employed by neutrophils upon death (Brinkmann et al. 2004). 
NETs are three dimensional web-like structures consisting of a backbone of nuclear chromatin 
(DNA and histones) decorated with granule proteins, mainly neutrophil elastase (NE) and 
myeloperoxidase (MPO). NETs can be triggered by different stimuli, such as phorbol-12-
myristate-13-acetate (PMA), lipopolysaccharide (LPS), calcium ionophores and different kinds 
of bacterial and fungal pathogens (Kenny et al. 2017). The extracellular traps are capable of 
capturing bacteria and degrading them at the site of infection (Brinkmann et al. 2004).  
1.3.1 Mechanisms of NET formation 
The process of NET formation and release has been defined as “NETosis” (Steinberg and 
Grinstein, 2007), a kind of cell death displaying features that differ from both apoptosis and 
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necrosis. During NETosis, the nuclear envelope disintegrates first and nuclear content mixes 
with the cytosol, then loss of intracellular membranes leads to the disappearance of cytoplasmic 
organelles. Lastly, the integrity of plasma membrane is lost and the NETs are released (Fuchs 
et al. 2007). Starting from the observation that the nuclear membrane of neutrophils is broken 
down during this process, similarly to the one of cells undergoing mitosis, Amulic and 
colleagues showed that PMNs, although terminally differentiated, upregulate core proteins in 
the cell cycle machinery when triggered for NET production, in order to mediate disassembly 
of the nuclear envelope (Amulic et al. 2017). The concept of NETosis as a form of cell death 
has been partly challenged. Kubes and colleagues described “vital NETosis” showing that 
NET-forming neutrophils in vivo can conserve their chemotactic function and cytoplasmic 
structures, including granules, and speculated that PMNs retain the necessary features to kill 
bacteria through conventional mechanisms (Yipp et al. 2012 and Yipp and Kubes, 2013).  
Furthermore, Pilsczek et al. described an early form of NET release via nuclear blebs delivered 
through the cytoplasm into the extracellular environment, thus maintaining the integrity of the 
plasma membrane (Pilsczek et al. 2010). The latest recommendation by the Nomenclature 
Committee on Cell Death has now adapted in light of the larger body of knowledge, and 
suggests to avoid the term NETosis whenever supporting evidence of cell death is not provided, 
recommending the choice of NET release or NET extrusion instead (Galluzzi et al. 2018). The 
origin of NET DNA has also been object of debate. Yousefi and colleagues revealed the 
presence of mitochondrial DNA as NET backbone, without detecting nuclear DNA (Yousefi 
et al. 2009). Considering these findings, it has to be taken into account that NETs can be 
triggered by a variety of stimuli, and that NETosis, as well as NET production, can be studied 
at different time points, thus potentially explaining diverse outcomes.  
Reactive oxygen species (ROS) are required for NET formation through the activation of 
NADPH oxidase, as patients suffering from chronic granulomatous disease (CGD) that have 
impaired NADPH oxidase function are defective in NET production (Fuchs et al. 2007). 
Conversely, an increasing number of reports indicate that NET release, for example in response 
to calcium influx or alteration in lipid composition in the plasma membrane, does not involve 
NADPH oxidase, but ROS of mitochondrial origin instead (Douda et al. 2015 and Neumann et 
al. 2014a). During NET formation, ROS trigger MPO-dependent dissociation of a granule 
complex containing NE, MPO and other granule proteins, so that NE is released into the cytosol 
and can digest F-actin allowing for the loss of cytoplasmic structure. NE can then translocate 
to the nucleus where it can partially cleave histones consenting chromatin decondensation 
(Papayannopoulos et al. 2010 and Metzler et al. 2014). Chromatin decondensation is also to be 
attributed to the calcium-dependent action of PAD4 that is capable of citrullinating histones 
(citrullinated histones are found in NETs) thus permitting a relaxed conformation of the nuclear 
chromatin (Rohrbach et al. 2012). 
1.3.2 Role in killing of pathogens 
Neutrophils release extracellular traps in response to a wide variety of bacteria, both against 
Gram-positive and Gram-negative bacteria (Brinkmann et al. 2004). The ability of NETs to 
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degrade pathogens in situ is to be attributed to the protease activity of NE, the peroxidase action 
of MPO (Parker et al. 2012a) as well as the antimicrobial properties of histones and LL-37 
peptides. Nevertheless, some bacteria seem to be endowed with mechanisms to escape NETs. 
Both Streptococcus pneumoniae and Staphylococcus aureus, for example, are trapped in NETs 
but not killed, due to their capability of degrading NETs using surface nucleases (Beiter et al. 
2006 and Thammavongsa et al. 2013). On the other hand, NETs-associated LL-37 has been 
described to protect NETs from degradation by nucleases from either S. pneumoniae or 
S.aureus (Neumann et al. 2014b).  
Interestingly, neutrophils seem to have the ability to modulate their defense strategy according 
to the size of the pathogen. The internal pool of NE can be directed towards phagocytosis or 
NET formation, depending on the microbe being in small form or large aggregates, such as 
hyphae (Branzk et al. 2014). The dectin-1 receptor, a receptor that recognizes β-glucan, has 
been indicated to mediate the size recognition, but this role is debated (Bryd et al. 2013 and 
Bachiega et al. 2015). Candida albicans is a clinically relevant pathogenic fungus, which 
presents the dimorphic phenotype of both cellular and filamentous hyphae forms. The capacity 
of NETs to counteract both forms of C. albicans accounts for 20-30% of the overall killing 
capacity (Urban et al. 2006), however, when C. albicans forms highly dense aggregates and 
layers biofilms, extracellular polysaccharide matrixes that shield the fungal colonies, NETs 
seem to be ineffective (Kernien et al. 2017 and Johnson et al. 2017).  
1.3.3 Role in diseases 
The same properties of NETs that constitute a clear benefit in host defense against microbes, 
such as the mesh structure providing a platform for proteolytic activity, have a role in the onset 
or aggravation of several pathologies (Papayannopoulos, 2017). 
A detrimental outcome linked to the NET structure is the promotion of thrombosis in the 
vasculature. Fuchs et al. showed how NETs provide a scaffold for platelet adhesion and 
aggregation promoting fibrin deposition. Treatment with DNaseI prevented thrombosis, thus 
confirming the role of NETs in this process (Fuchs et al. 2010). Furthermore, NE on NETs can 
use its proteolytical activity to cleave platelets receptors and coagulation inhibiting factors, thus 
promoting platelet accumulation and coagulation (Papayannopoulos, 2017). In addition, NETs 
have been described as a driving cause of pancreatitis. Similarly to the blood vessels, the 
pancreatic duct can be occluded by excessive formation of extracellular traps, which is 
triggered by bicarbonate or calcium carbonate crystals, highly present in the pancreatic juice 
(Leppkes et al. 2016).  
Involvement of NETs in the formation of atherosclerotic plaques has been investigated in both 
human and mouse models. Oxidized low density lipoproteins, hallmark of atherosclerosis, can 
induce NET release through TLR2 and TLR6 (Awasthi et al. 2016). In turn, NETs were found 
to prime macrophages for pro-IL-1β production, and consequent exposure to cholesterol 
crystals activated inflammasome-mediated secretion of IL-1β (Warnatsch et al. 2015). 
Moreover, ApoE-deficient mice fed with high fat diet developed atherosclerotic plaques rich 
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in cholesterol crystals surrounded by NETs, and in a double knock-out model where NE was 
also deleted, a reduced presence of NETs was assessed (Jorch and Kubes, 2017). 
Another area of study that is opening up in the last 5-6 years investigates the role of NETs in 
cancer. NET-rich microenvironments have been associated with a few kind of tumors in both 
mice and humans, but a clear evidence or link still needs to be delineated. Intestinal tumors 
with a disruptive phenotype for the intestinal barrier ease the leakage of LPS into the 
circulation, thereby promoting NET release and consequent coagulation in the surrounding 
vasculature, supporting the development of a tumorigenic microenvironment (Jorch and Kubes, 
2017 and Papayannopoulos, 2017). An original study by Cools-Lartigue et al. suggested a role 
for NETs in the establishment of tumor metastasis. The NET platform appeared to trap 
circulating tumor cells, favoring settlement of these cells and consequent metastatic formation 
(Cools-Latigue et al. 2013). 
High levels of glucose are capable of promoting NET release. PMNs isolated from patients 
with type I or type II diabetes were more prone to release the traps when stimulated with 
ionomycin, compared to healthy controls. Also, diabetic mice displayed high levels of 
citrullinated histones and a delay in wound healing, which were recovered by deletion of Pad4 
or administration of DNaseI, pointing at a role for NETs in the process (Wong et al. 2015). 
Moreover, in a cohort of type II diabetes patients related to a control population, significantly 
higher levels of circulating cell-free dsDNA and NE were assessed, compatible with a 
predisposition for NETs production (Menegazzo et al. 2015). 
1.3.4 Role in autoimmune diseases 
Autoimmune diseases are characterized by the development and production of antibodies 
directed against self-antigens. Anti-neutrophil cytoplasmic antibodies (ANCAs) are directed 
against intracellular neutrophil constituents: considering the known components of NETs 
(Urban et al. 2009), it is not difficult to imagine that a prompt removal from the extracellular 
environment is desirable in order to prevent antigen presentation and consequent 
auto-antibodies production. Kessenbroch et al. described the presence of MPO and PL3 
containing NETs ex vivo in kidney biopsies of small-vessel vasculitis patients (Kessenbroch et 
al. 2009). In this study, ANCAs have been shown to cause NETs production, triggering a 
self-sustaining loop that can exacerbate the disease. 
 
Similarly, neutrophils from patients suffering from rheumatoid arthritis (RA) presented 
enhanced NETosis compared to healthy controls or patients suffering from osteoarthritis. 
Furthermore, anti-citrullinated protein antibodies (ACPAs) present in high level in RA serum, 
were shown to induce NETosis and bind to NETs (Khandpur et al. 2013). Fibroblast-like 
synoviocytes, which play a major role in cartilage remodeling, were shown to have the 
capability of internalizing NETs through a RAGE-TLR9 mechanism, and consequently 
upregulate MHC-II molecules, compatible with the upregulation of pro-inflammatory 
cytokines (Carmona-Rivera et al. 2017). 
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The autoimmune disease that perhaps presents the tightest connection with NETs is SLE. 
Herrmann et al. reported reduced clearance of apoptotic cells by monocyte-derived 
macrophages from SLE patients, highlighting the deficiency of rapid and effective clearance 
of cell debris rather than abnormal apoptosis (Herrmann et al. 1998). Impairment in the 
clearance of apoptotic cells can lead to secondary necrosis thus exposing intracellular antigens 
triggering autoimmunity. Similarly, ineffective removal of NETs has been linked to the 
pathogenesis of SLE. According to the degradation rate of NETs by sera of SLE patients, two 
subpopulations have been described: one population whose sera can dismantle NETs 
efficiently and one not. The poor NET degradation has been linked to high levels of anti-NETs 
antibodies that shield NETs from DNaseI mediated digestion (Hakkim et al. 2010). Anti-NETs 
antibodies are also capable to recruit C1q on the NETs-immunocomplexes; C1q can in turn 
directly inhibit DNaseI thus further preventing NET degradation (Leffler et al. 2012). 
Conversely, Farrera and Fadeel showed that C1q enhances NET uptake by human 
monocyte-derived macrophages from healthy individuals and physiological concentration of 
DNaseI in serum are not sufficient to fully degrade NETs, thus highlighting the need for 
functional macrophage-mediated clearance of the extracellular traps (Farrera and 
Fadeel, 2013). The antimicrobial peptide LL-37 has been identified on NETs from SLE 
patients; the presence of LL-37 not only prevents DNaseI-mediated degradation of NETs but 
it is necessary to activate IFNα production by plasmacytoid DCs (Lande et al. 2011). Likewise, 
macrophages from SLE patients are more prone to release IL-1β via NLRP3 inflammasome 
activation upon LPS priming and exposure to LL-37, compared to healthy controls 
(Kahlenberg et al. 2013).  
From these observations, it appears clear how a functional battery of DNAses is of paramount 
relevance in preventing onset or exacerbation of SLE. Present in both murine and human 
serum, DNase1L3, produced by macrophages and DCs, has been shown to have the capacity 
of digesting microparticle-associated DNA of apoptotic origin (Sisirak et al. 2016) and to 
prevent vascular occlusion by NET DNA in mice (Jiménez-Alcázar et al. 2017). Moreover, a 
loss-of-function mutant variant of DNASE1L3 has been associated with SLE (Al-Mayouf et al. 
2011). Tightly linked to the IFN signature in SLE, aberrant sensing of cytosolic DNA needs to 
be prevented in order to avoid the immune response. Cytosolic DNA can undergo degradation 
by TREX1, a mechanism exploited also by viruses, as HIV, to keep their genomic material 
below threshold of detection (Yan et al. 2010). TREX1 is an ER-bound nuclease with cytosolic 
activity aimed to dismantle self-DNA to avoid its recognition by the cGAS-STING machinery 
(Barber 2015). Mutations in the gene encoding TREX1 have been associated with 
mislocalization of the protein, leading to the rise of SLE phenotypes in both mice and humans 
(Lee-Kirsh et al. 2007, Fye et al. 2011 and Grieves et al. 2015). 
1.4 ENGINEERED NANOMATERIALS 
According to the definition proposed in 2011 by the European Commission, a nanomaterial is 
“a material with one or more external dimensions in the size range of 1-100 nm” (Commission 
Recommendation of 18 October 2011). This definition clearly focuses on just one aspect of the 
particles, leaving room for discussion on what features have to be considered relevant to define, 
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especially in the framework of risk assessment for regulatory purposes (Maynard, 2011 and 
Gallud and Fadeel, 2015). The nanotechnology era has dramatically increased the production 
and use of nanomaterials on a global scale in everyday life: nanomaterials are used in fuel and 
grease, cosmetics, catalysts, electronics and drug carriers (Nel et al. 2006). Humankind has 
been exposed to nano-sized matters throughout its existence: from campfire combustion 
products to viruses, the human body has learnt to deal with a wide variety of nanoscale 
particles. The nanotechnology era has exponentially increased the variety of particles available 
(metal-based, organic and carbon based), as well as the chances for exposure, both accidental 
and occupational, to such an extent that questions about the safety of nanomaterials and the 
need for scientific research have arisen, leading to the development of nanotoxicology as a new 
field of investigation.  
1.4.1 Toxicity of nanomaterials 
Nanotoxicology aims to investigate the interaction between engineered nanomaterials and 
biological systems, emphasizing the fact that life itself is made possible by biological systems 
interacting on a nanosized scale (Shvedova et al. 2010). This interaction happens as a 
consequence of the biological systems encountering nanomaterials, a situation that can occur 
in the scenarios of occupational or accidental exposure, as well as voluntary exposure in the 
case of nanoparticles employed for biomedical applications. Occupational exposure might pose 
a risk when considering the proximity of the materials as well as the frequency of potential 
exposure, mainly through skin and airways (Kagan et al. 2010a), however it presents the 
opportunity of prevention by proper risk assessments, based also on the possibility to 
characterize the nanomaterials at site of production. On the other hand, accidental exposure 
might occur due to the inadvertent generation of nanomaterials, for instance in vehicle exhaust, 
as in the case of carbon nanotubes found in bronchoalveolar lavage fluids of asthmatic children 
in Paris (Kolosnjaj-Tabi et al. 2015), where characterization of the materials, or mixtures of 
materials, cannot be easily performed. 
  
When assessing the effects of nanomaterials on biological systems, the intrinsic properties of 
the material have to be considered, in particular when the ultimate goal is to exploit those 
properties for medical purposes, minimizing undesired effects (Fadeel et al. 2015). Size is of 
course relevant: the smaller the particle, the higher the surface area that can interact with the 
biological system. Also, different sizes in the nano-range can determine the ability of particles 
to cross barriers (blood-brain barrier, placenta, cellular membrane, nuclear membrane) and to 
be engulfed by professional phagocytes. Together with size, shape has also its relevance. 
Learning from the asbestos paradigm, high aspect-ratio particles, as fiber-shaped ones, that 
maintain a certain rigidity and are biopersistent in the biological environment bear 
characteristics that are at the base of their toxicity (Tran et al. 2011). As nanoparticles enter in 
contact with biological fluids, they gain a coating, or “corona” of biomolecules, such as protein 
and lipids, that determines the “biological identity” of the particle, or, in other words, what the 
cells “see” (Monopoli et al. 2012). Of note, the adsorbed proteins on the nanoparticle can 
change its surface properties, but the particle may also affect protein folding and induce 
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conformational changes that can lead to exposure of epitopes triggering unexpected cellular 
responses (Farrera and Fadeel, 2015). Surface charge and coating of the particle can determine 
the quality of the bio-corona, and different shapes of particles with the same chemical 
composition can lead to different responses. 
When assessing biocompatibility of nanomaterials, it is of primary importance to exclude 
endotoxin contamination that can be due to the synthesis process as well as further 
manipulation of the material. The importance of endotoxin testing is even more relevant when 
studying the interaction between nanoparticles and the immune system (Bhattacharya et al. 
2013). Excluding endotoxin contamination allows relating effects of the nanomaterial on the 
biological system to its intrinsic properties, disregarding confounding factors. 
For the evaluation of toxicity of nanoparticles, some considerations on doses and endpoints 
need to be regarded. In the multitude of studies addressing toxic outcomes of engineered 
nanoparticles, different metrics to describe the administrated in vitro dose are used, and 
correlation between the various metrics results not always straightforward. Furthermore, doses 
used are often not calibrated in a benchmark dose perspective, frequently resulting 
unrealistically high. Another issue faced by nanotoxicologists is to consider whether the 
nominal dose (the amount administrated) corresponds to the delivered dose (the amount that 
effectively reaches the cells) and which share of the delivered dose is eventually interacting 
with the cells or is ultimately internalized (Fadeel et al. 2015). 
 
Regarding the endpoints taken into account in nanotoxicology, an evaluation of cell death is 
often used as a first measure of toxicity. Returning a rough information, this evaluation is not 
very useful as unique endpoint, but it is functional to establish experimental conditions for 
investigating more fine parameters, as oxidative stress or damage to nucleic acids. For instance, 
genotoxicity driven by nanoparticles might arise from both direct interaction between the 
nanomaterial and the genetic material, as well as in an indirect form, via generation of 
nanoparticle-induced ROS, which in turn produce the oxidative damage on the nucleic acids. 
Nanomaterials in the 8-10 nm size range can cross the nuclear envelope and directly interact 
with DNA, while larger particles would gain access to DNA during the mitotic process 
(Magdalenova et al. 2014). Genotoxicity of nanoparticles (i.e. oxidation of DNA bases, single-
or double-strand brakes, interference with DNA repair mechanisms) might not result in swift 
cell death, and have effects, for instance, on transcription of genes, cell proliferation and 
tumorigenesis, therefore, appropriate assays for endpoints other than cell death are to be 
employed.  
1.4.2 Graphene-based nanomaterials 
Carbon based nanomaterials are, to date, one of the most active fields of interest in 
nanotechnology due to their versatility and variety of potential applications (Bhattacharya et 
al. 2016). Graphene, isolated for the first time in 2004 by Novoselov and co-workers, is a planar 
monolayer of carbon atoms bound together in hexagonal pattern, bearing excellent thermal and 
electrical conductivity as well as outstanding mechanical features, like strength and lightness 
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(Tonelli et al. 2015). One of the most relevant derivatives of graphene is graphene oxide (GO) 
which presents, on the surface of the carbon monolayer, oxygen epoxide groups as well as 
carbonyl, hydroxyl and negatively charged reactive oxygen groups that provide good water 
solubility to the material (Tonelli et al. 2015). 
 
Figure 2: Schematic classification of different kinds of graphene based on their fundamental 
properties: number of layers, lateral dimension, and carbon/oxygen ratio. The schematic 
drawings at the corners represent ideal cases. Reproduced from Wick et al. 2014, with 
permission from John Wiley & Sons, Inc. 
Besides the degree of oxidation, or carbon-to-oxygen ratio, which determines the 
hydrophobic/hydrophilic properties of the material and the consequent dispersibility in aqueous 
solutions, two other structural characteristics of graphene, with relevant implication for toxicity 
assessment, were taken into account by Wick et al. in proposing an approach to classify the 
different kinds of graphene, as depicted in Figure 2 (Wick et al. 2014). The lateral size 
determines the deformability of the material as well as the maximal dimension, which can vary 
from nanometers to micrometers and the number of layers defines both thickness and rigidity. 
These properties are key factors in the encounter with biological system as they influence 
cellular uptake and the ability to cross biological membranes (Wick et al. 2014). 
 
Graphene-based materials of biomedical interest are not limited to the different kinds of 
graphene depicted above. For instance, carbon nanotubes (CNTs) are cylinders made by 
graphene sheets: they can be constituted either by a single graphene sheet (single-walled carbon 
nanotubes, SWCNTs) or by several concentric layers of graphene (multi-walled carbon 
nanotubes, MWCNTs). CNTs bear diameters within the nanometer range, while length can 
span up to the micrometer range (Bhattacharya et al. 2016).  
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Due to its properties, graphene can be easily exploited for further surface functionalization, 
being a versatile tool to develop biosensors or drug carriers (Tonelli et al. 2015). Amongst the 
different applications tested, graphene-based materials have been shown to present suitable 
scaffolds for tissue engineering, providing a platform for cell adhesion, proliferation and 
differentiation (Nayak et al. 2011 and Park et al. 2011). Furthermore, due its structure, graphene 
can interact with nucleic acids through its hydrophobicity and π-π stacking, protecting them 
from degradation by nucleases (Lei et al. 2011), thus presenting a promising tool for gene 
delivery. 
1.4.3 Interactions of graphene-based nanomaterials with the innate immune 
system 
The immune system has evolved to defend the organism from potentially harmful non-self or 
modified-self matter, recognizing a wide variety PAMPs and DAMPs through PRRs on innate 
immune cells. Similarly, the notion of NAMPs has been proposed, based on the rationale that 
the innate immune system may treat nanomaterials in a similar fashion (Farrera and Fadeel, 
2015 and Mukherjee et al. 2018b). Once encountered an organism, nanomaterials for 
biomedical applications would interact with the immune system, either in the systemic 
circulation or in localized tissues. 
GO has been shown to not significantly affect cellular viability, ROS production or pro 
inflammatory cytokine release by HMDMs, whereas promoting macrophage activation and 
CD86 expression (Russier et al. 2013). Conversely, GO could activate both mouse and human 
macrophage cell lines in a size dependent manner, with larger graphene flakes triggering more 
robust activation and pro inflammatory cytokine production. On the other hand, as no 
endotoxin testing was performed in the study, the possibility that the effects reported were 
dependent on contamination cannot be ruled out (Ma et al. 2015). In another study, where 
control for endotoxin contamination was performed and the material classified as 
“endotoxin-free”, GO did not elicit loss of cell viability in primary HMDMs, but was 
promoting inflammasome activation and IL-1β secretion (Mukherjee et al. 2018a). 
Interestingly, evidence of large GO flakes lining along the plasma membrane of macrophages 
in a sort of “coating” has been reported and defined as “masking effect”, postulating that this 
phenomenon would be instrumental for either internalization of the material or loss of function 
or viability. The encounter of GO with the lipid bilayer of macrophage plasma membrane 
resulted also in piercing of the membrane or lipid extraction, depending on the different kinds 
of GO used (Mukherjee et al. 2017). Remarkably, macrophages were shown to be capable of 
digesting graphene based nanomaterials, namely CNTs, in a superoxide-peroxinitrite 
dependent manner (Kagan et al. 2014). The effect of different types of GO on DCs has been 
examined in a few studies, both in vitro and in vivo, focusing on the outcome for antigen 
presentation. In one study, GO was found to decrease antigen presentation to T cells, while 
other studies using GO to adsorb the antigen of interest revealed enhanced internalization of 
the GO-antigen complexes by DCs and subsequent antigen presentation (Mukherjee et al. 
2017). At the time of compiling this thesis, a lack of studies focusing on the interactions 
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between neutrophils and GO has been noticed, thus highlighting the relevance of the ones 
herein presented. However, effects of graphene based nanodiamonds have been investigated in 
a recent study, showing that the material would elicit NET formation in a mouse model (Muñoz 
et al. 2016). Moreover, in the same fashion as they capture conventional pathogens, NETs were 
shown to entrap and degrade oxidized SWCNTs in an MPO-mediated mode in an acellular 
system (Farrera et al. 2014). Furthermore, the administration of nanotubes to mice via 
pharyngeal aspiration elicited granuloma formation in the lung as well as a marked 
inflammatory response, whereas MPO-degraded nanotubes did not (Kagan et al. 2010b). Taken 
together, these studies suggest that the effects of graphene based nanomaterials on immune 
cells could be exploited when formulating vaccines, as they could act as adjuvants, and, as they 
present the possibility of not being biopersistent, could pose a limited risk for deleterious side 
effects. 
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2 AIM OF THE STUDY 
 
Since their discovery in 2004, NETs have gained considerable attention in both basic cell 
biology and immunology as well as in clinical medicine, bridging together different areas of 
investigation. The overall aim of this study is to deepen the knowledge of NETs in a 
multidisciplinary context, with a focus on the mechanisms of formation and disposal of NETs, 
and their roles in both infectious and non-infectious conditions. 
The specific aims are: 
- To study the inflammatory responses to NETs in macrophages and DCs 
- To identify the nucleases involved in degradation of NETs in phagocytic cells 
- To assess whether JAGN1 is involved in the production or function of NETs  
- To determine if and how GO sheets of different lateral dimensions trigger NETs 
- To study extracellular biodegradation of GO and toxicity of the degradation products 
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3 METHODOLOGIES 
In this section, critical considerations on methods and models used in the constituent papers of 
this thesis, as well as a description of the experimental protocols are provided. A detailed 
description of the experimental conditions is available in the method section of each constituent 
paper. 
3.1 CELL MODELS 
3.1.1 Primary human cells 
Primary cells offer a number of advantages, as well as some downsides compared to cell lines. 
As ex vivo model, primary cells bear the characteristics of the tissue of origin and higher 
resemblance to the in vivo scenario, furthermore, in the case of non-cancerous primary cells, 
they present lower mutation rate compared to tumor cell lines. On the other hand, primary cells 
might require time-consuming isolation procedures and more careful culture methods, while 
presenting a generally shorter lifespan in culture. Additionally, the variability between batches 
of isolated primary cells reflects individual variability in the population of donors, which is lost 
with the use of clonal cell lines. 
 
Primary human neutrophils from healthy blood donors were isolated from buffy coat using 
density gradient centrifugation followed by gradient sedimentation in a 5% dextran solution 
and hypotonic lysis of residual erythrocytes. The same procedure was applied for the isolation 
of primary neutrophils from the SCN patient. For NET production, freshly isolated neutrophils 
were maintained in serum-free RPMI 1640 medium supplemented with 2 mM L-glutamine, 
100 U/mL penicillin and 100 µg/mL streptomycin and treated with 25 nM PMA for 2 or 3 
hours. Production of NETs was performed in absence of serum, since heat-stable nucleases, 
capable of degrading NETs, are present in sera ordinarily used as cell culture supplement 
(von Köckritz-Blickwede et al. 2009). Purified NETs were obtained removing 
PMA-containing supernatants and adding fresh HBSS or RPMI. Thorough pipetting was 
carried out and the mixture was centrifuged at 1500 rpm for 5 min. Eventually, supernatant 
containing NETs were retrieved and used for further assays. 
 
Buffy coat from healthy blood donors was the source for primary monocytes, isolated via 
density gradient centrifugation followed by positive selection with CD14 MACS magnetic 
beads. Monocytes were maintained in RPMI 1640 medium supplemented with 2 mM 
L-glutamine, 100 U/mL penicillin and 100 µg/mL streptomycin in the presence of 10% FBS. 
Differentiation into macrophages (HMDMs) was performed using 50 ng/mL recombinant 
human M-CSF for 3 or 4 days, while culture medium was supplemented with 16 ng/mL 
recombinant human GM-CSF and 50 ng/mL recombinant human IL-4 in order to obtain 
dendritic cells (MDDCs). 
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3.1.2 Cell lines 
The human acute promyelocytic leukemia cell line HL-60 (Collins et al. 1977) was purchased 
from ATCC and maintained in RPMI 1640 medium supplemented with 2 mM L-glutamine 
and 10% FBS in absence of antibiotics. HL-60 cells can be differentiated into neutrophil-like 
cells using various stimuli, like all-trans retinoic acid, dimethylformammide and dimethyl 
sulfoxide (DMSO). In our study (Paper II) we achieved optimal differentiation using 1.25% 
DMSO for 5 days, substituting the medium with fresh one after 3 days of culture (Arroyo et al. 
2002). The HL-60 model was chosen for its particular suitability to our scope, being a 
promyelocytic cell line, which resembles the stage of maturation arrest in the development of 
myeloid progenitors in the bone marrow of SCN patients. Furthermore, we could establish an 
HL-60 model in which transient downregulation of JAGN1 was significant and not interfering 
with the differentiation process. 
 
The BEAS-2B human bronchial epithelial cell line was purchased from ECACC and cultured, 
according to the manufacturer’s guidelines, in bronchial epithelial cell growth medium 
(BEGM) supplemented with GA-1000 (gentamicin sulfate and amphotericin-B), retinoic acid, 
epinephrine, transferrin, triiodothyronine, bovine pituitary extract, insulin, hydrocortisone and 
recombinant epidermal growth factor (EGF). Cells were seeded on surfaces pre-coated for 2 h 
with 0.01 mg/mL fibronectin and 0.03 mg/mL bovine collagen type I in BEGM basic medium 
with addition of 0.01 mg/mL bovine serum albumin and 0.2% penicillin-streptomycin. 
BEAS-2B cells are SV40-immortalized normal bronchial epithelial cells explanted from 
autopsies of cancer-free individuals (Reddel et al. 1989) that are not tumorigenic when injected 
in nude mice. In Paper IV, BEAS-2B cells were selected to study DNA damage originating 
from degradation products of GO, as this cell line is noncancerous and a relevant model for 
inhalation exposure. 
3.2 NET FORMATION AND DEGRADATION 
In order to evaluate formation of NETs, complementary methods have been used: qualitative 
imaging using scanning electron microscopy or confocal microscopy with staining for the 
major NET components, and quantitative measurements via SYTOX green assay or NE assay. 
3.2.1 Scanning electron microscopy (SEM) 
For SEM imaging (Paper III), freshly isolated neutrophils were seeded on poly-L-lysine coated 
coverslips and exposed to either PMA, control media or graphene flakes for 3 h. Fixation was 
performed with 2.5% glutaraldehyde in phosphate buffer, samples rinsed and sequentially 
placed in 70% ethanol for 10 min, 95% ethanol for 10 min, absolute ethanol for 15 min 
followed by acetone treatment. Samples were dried in a controlled CO2 system, mounted on 
aluminium stub and coated with carbon prior to be analyzed in an Ultra 55 field emission 
microscope (Zeiss, Oberkochen, Germany). 
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3.2.2 Confocal microscopy 
Freshly isolated primary human neutrophils were seeded in poly-L-lysine coated coverslips 
and stimulated with PMA for 2 h, then cells were fixed with 2% PFA in PBS and stained for 
MPO (Paper I and Paper II), LL-37 (Paper I), NE (Paper II and Paper III) and counterstained 
with DAPI. Visualization of the samples was performed on a ZEISS LSM510META confocal 
microscope. For the HL-60 cells, incubation with PMA was carried out for 3 h and, after 
fixation as described above, the sample were probed for MPO and counterstained with SYTOX 
green for visualization of the DNA fibers. The mere staining and imaging of extracellular DNA 
fibers can lead to controversial interpretation of the results, as extracellular DNA can be the 
product of other cell death modalities, as necrosis. It is therefore important, when assessing the 
presence of NETs, to combine DNA staining with immunostaining for at least one of the 
proteinaceous component of NETs, and verifying their co-localization (Jorch and Kubes, 
2017). 
3.2.3 SYTOX green assay 
With the aim to have a measure of NET formation, HL-60 cells, transfected with either control 
siRNA or siRNA targeting JAGN1, were seeded in HBSS at a density of 0.1 x 106 cells / well 
in a black 96-well plate and incubated with or without PMA for 3 h. Incubation with SYTOX 
green (5µM) was performed for 15 min prior to analyze fluorescence emission at 523 nm in an 
Infinite F200 Tecan plate reader. SYTOX green is a DNA-intercalating dye, which can not 
cross the plasma membrane of living cells, thus being able to detect only extracellular DNA, 
upon the binding of which it becomes highly fluorescent (Vong et al. 2013). 
3.2.4 NE assay 
For measuring NET production in response to GO, the SYTOX green assay was found to be 
not suitable, as the material was interfering with the measurements, so the NE assay was chosen 
instead. Freshly isolated neutrophils were seeded at a density of 0.2 x 106 cells / well in  96-well 
plates and exposed to 12.5 µg/mL of small or large GO flakes, 25 nM PMA, 10 mM MβCD or 
control RPMI media for 3 h. In some experiments, the cells were pre-incubated for 30 min with 
one of the following inhibitors: 10 µM DPI, 500 µM Trolox or 10 µM MitoTEMPO, or the 
experiment was conducted in the presence or absence of 10 mM EGTA. After exposure, the 
samples were subjected to extensive pipetting and centrifuged at 1600 rpm for 5 min, then 
150 µl of supernatants were retrieved. To digest NET DNA and let NET-bound NE be available 
for the assay, 50 µl of the so-obtained supernatants were incubated with 0.3 U/µL of DNAseI 
for 15 min. Then, 50 µl of assay buffer containing N-(methoxysuccinyl)-Ala-Ala-Pro-Val-
4-nitroanilide were added and absorbance at 405 nm was detected with an Infinite F200 Tecan 
plate reader after 3 h of incubation. N-(methoxysuccinyl)-Ala-Ala-Pro-Val-p-nitroanilide is a 
specific substrate for NE, which enzymatically cleaves the substrate releasing 4-nitroaniline, 
whose absorbance can be detected at 405 nm (Castillo et al. 1979).  
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3.2.5 Extracellular degradation of NETs 
Agarose gel electrophoresis was performed with the aim to check the extracellular degradation 
of NETs. After addition of purified NETs to MDDCs, supernatants were collected at different 
time points and enzymatic activity of DNase1L3 was promoted with addition of 2 mM CaCl2 
and 2 mM MgCl2 for 1 h at 37°C. Samples were then subjected to 1% TAE agarose gel 
electrophoresis, detection was performed with Sybr green I and the gel was visualized in a 
Molecular Imager scanner (Bio-Rad). Undigested purified NETs, being of high molecular 
weight, would not run through the gel, packing instead close to the loading well, while 
fragmented digested NETs would run through the gel, resulting in the disappearance of the 
signal from the area close to the loading well. 
3.3 UPTAKE OF NETs BY MACROPHAGES AND DENDRITIC CELLS 
Uptake of NETs was evaluated using confocal microscopy. For some experiments, 
pre-incubation with CellTracker Orange for 30 min was performed, otherwise, HMDMs or 
MDDCs were seeded on glass coverslips and stained for 15 min with Hoechst 33342. Then, 
media containing Hoechst staining were removed, samples washed, and purified NETs, 
pre-incubated with SYTOX green for 15 min, were added to the cells. For some experiments, 
Lysotracker Red was added 30 min before fixation of the samples, in order to visualize 
lysosomes. Incubation of purified NETs with cells was carried out for 1 h, then fixation with 
2% PFA in PBS was performed, coverslips were mounted on glass slides and visualized in a 
ZEISS LSM 880 confocal microscope. The CellTracker dye, which binds unspecifically to all 
the proteins in the cells, was used in order to confirm the intracellular localization of the 
engulfed NETs. The cell-permeable DNA dye Hoechst 33342 was chosen to mark nuclear 
DNA of the phagocytes, and removed before addition of the SYTOX green-labeled NETs in 
order to allow for the discrimination between DNA of phagocyte origin and NET DNA. 
Extranuclear green DNA dots were considered as engulfed NETs and cells presenting such 
phenotype were considered as positive when scoring the samples. 
3.4 GENE EXPRESSION AND DOWNREGULATION 
Constitutive expression of relevant genes in Paper I and Paper II was determined quantifying 
specific mRNA transcripts using quantitative Real-Time PCR (RT-qPCR). The same technique 
was adopted to assess the degree of downregulation of selected genes after transfection with 
specific siRNAs. 
3.4.1 Real-Time quantitative PCR 
In order to purify total RNA from samples intended to be analyzed with RT-qPCR, a silica 
membrane column based method was chosen over organic phase extraction methods. Besides 
avoiding the use of chloroform-containing reagents, the column purification yields high quality 
RNA, with minimal proteinaceous impurities. Furthermore, the QIAGEN RNeasy Mini Kit 
used for extraction of total RNA, allows for on-column DNA digestion, thus minimizing DNA 
contamination of the samples. Total purified RNA was quantified using the Nanodrop 
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platform; thereafter 1 µg of total RNA was subjected to reverse transcription with the Revert 
Aid-H Minus First Strand cDNA Synthesis Kit (Thermo Scientific). Samples were analyzed 
using specific primers and SYBR green probing on an Applied Biosystem 7500 Real-Time 
PCR System. 
3.4.2 Silencing of DNaseII, TREX1, DNase1L3 and JAGN1 
Silencing of DNaseII and TREX1 in HMDMs was performed delivering 3 µM of specific 
siRNAs into the cells, after 2 days from isolation, using the Amaxa Nucleofector 2B 
electroporation platform, following the guidelines from the manufacturer. Silencing efficiency 
was evaluated after further 2 days of culture of the cells in the relevant media. For 
downregulation of DNASE1L3 and JAGN1 the method of choice for transfection of specific 
siRNAs was the Lipofectamine 3000 reagent used in complex with 75 nM siRNA targeting 
DNASE1L3 or 50 nM of specific JAGN1 siRNA. Electroporation is a quite harsh transfection 
method, which involves the use of high-voltage electric pulses, applied for short time, that 
perturb the plasma membrane structure creating pores, which allow the transfer of nucleic acids 
into the cells (Potter and Heller, 2018). This is quite a straightforward technique and allows for 
the transfection of a large number of cells in short time, however, cell viability might be 
markedly impaired. The use of cationic lipids, as Lipofectamine 3000, on the other hand, 
displays generally lower cytotoxicity in relation to electroporation. Cationic lipids are exploited 
to form complexes with the negatively charged nucleic acids, such as siRNAs, with an overall 
positive charge of the complex, allowing them to be attracted to the cell membrane and ease 
internalization (Kim and Eberwine, 2010). 
3.5 PROTEIN EXPRESSION 
3.5.1 Western blot 
Western blot experiments were used in order to have semi-quantitative information on protein 
expression and / or release in purified NETs or cell culture supernatants and were carried out 
following standard procedures. For MDDCs (Paper I) and primary neutrophils (Paper II) cell 
pellets were lysed with Radioimmunoprecipitation assay (RIPA) buffer, while HL-60 cell 
pellets were lysed in CellLytic M buffer. RIPA buffer is the buffer of choice for the lysis of 
neutrophils, as it allows for thorough membrane extraction, however, its preparation is 
time-consuming and the shelf life short, compared with the more stable CellLytic M buffer. 4-
20% Tris-Glycine gradient gels were used in Paper II, as they warranty higher resolution for 
low molecular weight proteins, as MPO (15 kDa subunit) and FLAG-tagged JAGN1 
(~20 kDa), while 4-12% SDS-PAGE gels were chosen for Paper I. When using cell culture 
supernatants as samples for western blot, it is difficult to choose a housekeeping protein in 
order to normalize the results, thus a total protein staining intermediate step was carried out. 
Membranes were probed with specific primary antibodies and IRDye secondary antibodies, 
suitable for detection with an Odissey CLx LI-COR Biosciences scanner. 
 26 
3.5.2 Enzyme-linked immunoassorbent assay (ELISA) 
This assay was used to quantify MPO in cell lysates and purified NETs obtained from HL-60 
cells (Paper II). A commercially available ELISA kit for MPO was purchased from 
eBioscience /Affymetric and used according to the manufacturer’s guidelines, which are based 
on conventional Sandwich ELISA protocols. Sandwich ELISA offers high specificity, as it 
employs two antibodies directed towards different epitopes of the target, thus not requiring pre-
processing purification steps of complex samples. 
3.6 PHENOTYPICAL ASSESSMENT OF CELLS 
3.6.1 Microscopy 
With the aim to monitor morphological variation of HMDMs and MDDCs in response to NETs 
and LPS (Paper I), bright field microscopy was used. Cells were seeded at a density of 
0.5 cells / well in 24-well plates, exposed to different stimuli for 1 h, then exposure media were 
washed out and replaced with fresh ones for further 24 h. After 24 h, the samples were 
visualized with an inverted fluorescence microscope (Nikon ECLIPSE TE2000-s) using the 
bright field option. In order to assess differentiation of HL-60 cells into neutrophil-like cells, 
nuclear morphology was evaluated (Paper II). Staining with the DNA-binding fluorescent dye 
DAPI was exploited for visualization of cell nuclei and samples were scored for round nuclear 
morphology (undifferentiated) versus kidney-shaped or multi-lobular morphology 
(differentiated). 
3.6.2 Flow cytometry 
Flow cytometry analysis was carried out on a BD Accuri C6 flow cytometer and data analyzed 
with BD Accuri software. For differentiation of HL-60 cells (Paper II), upregulation of CD11b 
was evaluated. CD11b is one of the subunit constituent of integrin αMβ2, which regulates 
adhesion and migration of innate immune leukocytes and whose expression is higher in mature 
neutrophils compared to the promyelocyte progenitors (Martinelli et al. 2004). In Paper I, 
activation and maturation of MDDCs in response to NETs and LPS was monitored using CD80 
and CD86 as markers of activation and CD83 as maturation marker. Both CD80 and CD86 are 
capable of binding CD28 on the surface of T-cells and are required as co-stimulatory molecules 
in the activation of T-cells (Lanier et al. 1995), while CD83 is needed for T-cell maturation in 
the thymus (Breloer and Fleischer, 2008). 
3.7 MULTIPLEX ASSAY FOR SOLUBLE MEDIATORS 
The Luminex Bio-Plex Pro Human Cytokine Panel 27-plex (Bio-Rad) was utilized for analysis 
of cytokines, chemokines and growth factors released by HMDMs and MDDCs in response to 
NETs and LPS. The Luminex assay is a based on a principle that resembles a sandwich ELISA 
protocol, making use of magnetic beads, which present specific and well-defined fluorescence 
properties, coated with capture antibodies. In the kit used in Paper I, 27 different kinds of beads, 
coated each with specific antibodies against one of the soluble mediators in the panel, were 
mixed with the samples. Being the beads magnetic, washing steps performed on a magnetic 
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wash station allowed for elimination of all the sample components that not bind to the capture 
antibodies, or the excess of reagents. Biotinylated detection antibodies are added to the system 
and phycoerythrin (PE)-conjugated streptavidin is used for labeling the complexes. Samples 
are eventually read in a flow cytometry system. The fluorescence signal originating from the 
beads is associated to the specific soluble mediators while the fluorescence intensity of PE is 
proportional to the amount of the specific analyte (Bhattacharya et al. 2017). The Luminex 
platform offers the possibility to assess a large panel of soluble mediators using very limited 
volume of sample, even with complex composition, offering a quite broad dynamic range that 
allows minimal optimization steps. Furthermore, compared to conventional ELISA assays, 
detection limits for most soluble mediators are lower and the protocol is not more 
time-consuming. 
3.8 FUNGI AND FUNGAL KILLING ASSAYS 
Candida albicans (strain SC5314, ATCC MYA-286) was obtained from ATCC. For the 
experiments, C. albicans was subcultured at an OD595 of 0.1 in RPMI 1640 medium with 2% 
glucose at 37°C for 4 h in order to induce the formation of hyphae, while the culture was 
maintained in YPD (1% yeast extract, 2% bacto peptone and 2% glucose) at 30°C for the yeast 
form. C. albicans was chosen as a model pathogen for its susceptibility to neutrophil and 
NETs-mediated killing in both hyphae and yeast form in a size-dependent fashion (Urban et al. 
2006 and Branzk et al. 2014). For the evaluation of fungal killing capacity of NETs (Paper II), 
purified NETs obtained from HL-60 cells transfected with either control siRNA or JAGN1 
siRNA were incubated with C. albicans at MOI of 0.01 for 2 h at 37°C. In some experiments, 
purified human MPO (0.066 µM) was added to the JAGN1 deficient purified NETs prior to 
incubation with the fungi. After 2 h, OD595 was used as a readout of the survival of C. albicans 
and from the same samples, 50 to 500 CFU were seeded on YPD agar plates and cultured for 
24 h at 37°C, then colonies were counted. 
3.9 CELL VIABILITY ASSAYS 
For cell viability assessment of neutrophil exposed to GO (Paper III), the luminescence-based 
Cell Viability Kit SL (BioThema, Sweden), measuring total cellular ATP which is rapidly 
degraded upon cell death, was utilized. The kit exploits the D-luciferin-luciferase system: in 
presence of ATP and O2, D-luciferin is converted by luciferase into oxyluciferin, with the 
reaction liberating pyrophosphate from ATP and light. The intensity of the light can be 
measured with a luminometer and is proportional to the amount of ATP, thus giving a measure 
of cell viability (Lundin, 2000). This assay was selected because it had no interference with the 
carbonaceous nanomaterial and, unlike other assays as Alamar Blue, it was well suited for the 
short lifespan of neutrophils in culture and time points selected in this study. 
 
In order to assess cytotoxicity of the biodegradation products of GO to the BEAS-2B cell line 
(Paper IV), the Alamar Blue assay was utilized. In this assay, resazurin is added to the cell 
culture in order to monitor the redox state of the culture environment (Lancaster and 
Fields, 1996). Resazurin, a non-fluorescent blue-colored and oxidized redox indicator, is 
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reduced to resorufin, which is fluorescing at ~580 nm and red-colored, as a result of the 
metabolic activity of the cells that causes a chemical reduction of the culture environment. Data 
collection can be performed measuring either fluorescence (Ex. 530-560 nm, Em. 590 nm) or 
absorbance (570 nm and 600 nm). The Alamar Blue assay is well suited for assessment of 
cytotoxicity over medium to long time exposure, as it does not affect cell viability, thus being 
useful to monitor both cell death and cell proliferation. 
3.10 CALCIUM DYNAMICS 
With the aim to measure the variation of intracellular concentration of calcium ions (Ca2+) in 
response to GO, freshly isolated neutrophils were treated with the Fluo-4 Direct Calcium Assay 
Kit (Invitrogen), according to the manufacturer’s protocol. Then, neutrophils were exposed to 
12.5 µg/mL of GO, small or large flakes, up to 180 min. The Ca2+ ionophore ionomycin (1 µM) 
was used as positive control. Measurements of fluorescence, which is directly proportional to 
the content of intracellular calcium ions, were taken at different time points using an Infinite 
F200 Tecan plate reader (Ex 485 nm; Em 535 nm). Intracellular calcium measurements, using 
molecules that fluoresce upon binding Ca2+, present several challenges, as high background 
fluorescence and rapid extrusion of the probe from the cells. For these reasons, the 
above-mentioned kit was chosen, as it contains an additional dye meant to eliminate 
background fluorescence from cell culture media as well as probenecid, which inhibits organic 
anion transporters thus hindering active excretion of the probe from the cells and reducing 
background fluorescence due to extracellular Ca2+ binding. 
3.11 DETECTION OF MITOCHONDRIAL SUPEROXIDE 
For detection of mitochondrial superoxide production by neutrophils in response to GO, the 
MitoSOX Red probe (Invitrogen) was used according to the manufacturer’s guidelines prior to 
exposure of the cells to small or large flakes of GO. The MitoSOX Red probe is rapidly 
permeating living cells and selectively localizing in the mitochondria, where it can be readily 
oxidized by mitochondrial superoxide, but not by other ROS. Oxidized MitoSOX Red displays 
high fluorescence upon binding to nucleic acids, which is proportional to the amount of 
superoxide generated by mitochondria. Exposure of MitoSOX-labeled neutrophils to GO was 
carried out in the presence or absence of the selective calcium-chelating agent EGTA (10 mM), 
to highlight the Ca2+-induced superoxide production. Fluorescence emission was detected at 
different time points using an Infinite F200 Tecan plate reader (Ex. 540 nm; Em 590 nm). 
3.12 CHOLESTEROL MEASUREMENTS AND DETECTION OF LIPID RAFTS 
The Cholesterol Assay Kit (Abcam) was utilized, according to the manufacturer’s instructions, 
for analyzing cholesterol dynamics in the membranes of neutrophils exposed to small or large 
flakes of GO or MβCD in the presence or absence of the antioxidant Trolox. The kit, optimized 
for detecting cholesterol in biological membranes, uses filipin III, a selective fluorescent 
cholesterol-binding macrolide antibiotic, as a probe. Filipin III is highly light sensitive and 
photobleaches rapidly, thus staining procedures and detection were performed minimizing the 
exposure of the samples to light. Detection of cholesterol-bound filipin III was performed using 
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either a Tecan Infinte F200 plate reader (Ex. 360 nm; Em 465 nm), for quantitative information, 
or a ZEISS LSM510 META confocal microscope for direct visualization of membrane 
cholesterol in neutrophils. Lipid rafts, functional protein-rich plasma membrane domains 
(Lingwood and Simons, 2010), were visualized staining PFA-fixed samples with Alexa Fluor 
594-Conjugate recombinant cholera toxin B (CTXB) for 45 min and visualized using a ZEISS 
LSM510 META confocal microscope. The use of CTXB to visualize lipid rafts domains in the 
plasma membrane is due to its capacity of binding sphingolipids, one of the major lipid 
components of these domains, without posing toxicity, as the cytotoxic A subunit of the protein 
is not present in the recombinant form. 
3.13 CHARACTERIZATION OF GRAPHENE OXIDE 
Thorough characterization of the material is of outmost importance in order to understand its 
interactions with biological systems and the possible mechanisms of toxicity that the material 
could elicit. It is important to bear in mind that intrinsic properties of the pristine material can 
vary according to the dispersion media used; therefore, characterization in the relevant 
exposure media should not be neglected. To this aim, a panel of techniques has been exploited 
to evaluate different physicochemical properties of the graphene oxide flakes used in Paper III 
and Paper IV. The GO materials were synthesized at the University of Manchester, UK. 
Lateral dimension and thickness. For the evaluation of structural properties of GO, optical 
microscopy, TEM and AFM were used. In order to determine lateral dimension, bright field 
optical microscopy using a Zeiss PrimoVert microscope was used. Furthermore, TEM analysis 
of GO samples was performed on a Tecnai 12 BioTwin (Philips/FEI) 100kV electron 
microscope, drop casting the samples on a formav-carbon-coated copper grid. AFM was 
employed for the assessment of both lateral dimension and thickness. Briefly, 20µl of sample 
were casted on a freshly cleaved mica surface coated with poly-L-lysine and allowed to adsorb 
for 5 min. Excess unbound GO was removed with Milli-Q water and the sample was air-dried 
prior to analysis using a multimode microscope in tapping mode equipped with a J-type 
scanner, OTESPA silicon probe (Bruker, Coventry, UK) and a Nanoscope V controller 
operating with NanoScope Analysis software v.1.40 (Veeco, Cambridge, UK). 
Optical properties. Absorbance of both small and large GO flakes was evaluated using a Varian 
Cary winUV 50 Bio spectrophotometer scanning the peak wavelength and maximum 
absorbance ranging from 200 to 800 nm, while fluorescence emission spectra were collected 
with a LS-50B PerkinElmer spectrofluorometer at an excitation wavelength of 525 nm. 
Surface charge and aggregation. Surface charge is a very relevant property of materials 
introduced in biological environment, which can be affected, together with aggregation, by the 
composition of the media utilized for dispersion of the material. With this in mind, zeta 
potential measurements were performed for both the pristine materials and material dispersion 
in the relevant exposure media. To this aim, electrophoretic mobility, which relates to zeta 
potential as per Henry’s equation, was measured with a Malvern Zetasizer Nano ZS (Malvern 
Instruments, UK). It is important to consider that this technique is optimized for measurements 
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of spherical particles (Retamal Marin et al. 2017). Nevertheless, it can give an approximate 
indication on the surface charge of non-spherical materials as well as information on the 
stability of the material in suspension in different dispersion environments. 
Raman spectroscopy measurements were recorded using a Thermo Scientific DXR 
micro-Raman spectrometer equipped with a 50x objective at 633 nm laser excitation and an 
exposure time of 25 s, after air-drying of the samples on glass slides. This technique is highly 
suitable to study graphene based materials (Beams et al. 2015), which present a characteristic 
Raman signature peak at ~1580 cm-1 (G-band), representative of sp2 carbon-carbon stretching, 
and, in case of any defect breaking the symmetry of the carbon monolayer structure, a disorder-
induced D-band at ~1350 cm-1. 
Chemical composition and degree of functionalization. For the analysis of the chemical 
composition of GO, thus confirming its purity, X-ray photoelectron spectroscopy (XPS) was 
used in combination with thermogravimetric analysis (TGA) to define the degree of 
functionalization. These two methods allow to describe the precise atomic structure of the 
material, delivering information on the degree of oxidation, which is relevant for the 
dispersibility and the stability in aqueous suspension of the material. TGA was performed in a 
Pyris 6 analyzer instrument (PerkinElmer) using 1-2 mg of starting material, while XPS 
analysis was carried out at the NEXUS facility at the National EPSRC XPS Users’ Service, 
nanoLAB, Newcastle-upon-Tyne, UK. 
3.13.1  Endotoxin contamination 
When evaluating effects of nanomaterials on immunocompetent cells, it is good practice to 
exclude contamination of the material with endotoxin, which could arise from non-sterile 
synthesis methods or improper conservation and handling practices. The endotoxin limit for 
products that enter in contact with the lymphatic or the cardiovascular system is 0.5 EU/mL 
(FDA guidelines, June 2012) corresponding to 0.05-0.1 ng of endotoxin per mL. Usually, 
endotoxin contamination of nanomaterials is assessed with the LAL (Limulus Amebocyte 
Lysate) assay, however, graphene based nanomaterials interfere with the absorbance 
wavelengths used as readout of this method (Mukherjee et al. 2016). In order to circumvent 
this issue, GO used in Paper III and Paper IV was tested using the TNF-α expression test. In 
brief, primary HMDMs (obtained as described above in this method section) were exposed to 
either LPS or GO in the presence or absence of the specific endotoxin inhibitor polymyxin B, 
and TNF-α release was measured after 24 h exposure using a commercially available human 
TNF-α ELISA kit (Abcam). 
3.13.2 Carbon radicals and acellular oxidation 
Electron paramagnetic resonance (EPR) was exploited for verifying the presence of carbon 
radicals on GO. Dry lyophilized GO sheets (1.5 mg) were placed in an EPR tube and 
measurements were performed at room temperature on a EMX XBand Bruker spectrometer. 
When applying a magnetic field, the gap between the energy states of paired electrons is 
widened, so that, while paired electrons reside within their energy levels, unpaired ones are 
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free to move between the two distinct levels. As more electrons are generally harbored at lower 
energy state, unpaired electrons can move to higher energy levels by absorption of energy, 
which can be recorded in an EPR spectrum. In order to achieve a higher signal-to-noise ratio, 
EPR spectra are presented as first derivative of the absorption spectrum. 2,7-
dichlorofluorescein-diacetate (DCF-DA) is a fluorescein derivative often used for measuring 
intracellular ROS. Deacetylation of the probe, mediated by intracellular esterases, is functional 
to the retention of the compound inside the cells. The deacetylated compound (HDCF) is a 
non-fluorescent molecule, which becomes fluorescent upon oxidation (Bilski et al. 2002). In 
Paper IV, as aimed for an acellular assay, HDCF was used as a probe to detect oxidation 
mediated by carbon radicals on GO, incubating 25 µM of the probe with different 
concentrations of small or large GO flakes for 10 min. Fluorescence intensity (Ex. 485 nm; 
Em. 535 nm) was measured using a Tecan Infinite F200 plate reader and values normalized for 
auto-fluorescence of GO. 
3.14 TIME-of-FLIGHT SECONDARY ION MASS SPECTROMETRY 
Secondary-ion mass spectrometry (SIMS) is based on the principle that acceleration of 
high-energy ions (primary ions) onto a surface, results in the target surface scattering secondary 
ions, characteristic of its chemical composition, which can be analyzed in a mass spectrometer, 
using various analyzers, as Time-of-Flight (ToF) (Fletcher et al. 2011).  
Figure 3: schematic representation of the ToF-SIMS principle. Adapted from Bolles et al. 2010. 
Materials (Basel). 3: 3948-3964. 
As outlined in Fig. 3, imaging ToF-SIMS is a technique to analyze mass spectra in relation to 
each pixel of the ion image of origin, thus allowing to obtain information about localization of 
biochemical identities, which is otherwise lost with conventional mass spectrometry 
techniques, without the need of a labeling strategy (Nygren and Malmberg, 2007). Being 
primary ion beam 
secondary ions 
sample 
sample support 
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particularly useful in profiling sugars and lipids, ToF-SIMS can be employed to outline 
biological samples, as tissue sections or monolayers of cells, both at the surface (i.e. cell 
membrane) and for depth profiling analysis, a sort of “coring” into the cells. A current 
limitation of using imaging ToF-SIMS for the analysis of biological samples is related to the 
sources of primary ions. The optimal sources for bio-imaging purpose, as Bi3+, produce 
secondary ions whose mass signature has yet to be completely mapped, and does not fully 
overlap with mass spectra obtained from conventional mass spectrometry techniques. 
However, use of standards for comparison purposes can overcome this difficulty (Nygren and 
Malmberg, 2007). In Paper III, Bi3+ were used as primary ion sources for surface mapping of 
PMNs exposed to small or large GO, MβCD, PMA or control media, or for analyzing 
cholesterol oxidation in acellular samples. Samples were examined with a TOF-SIMS V (ION-
TOF GmbH, Münster, Germany) in positive and negative ion mode using The SurfaceLab 6 
software (v.6.6, ION-TOF) for acquisition, processing and analysis. For depth profiling, 
sputtering with C60
3+ ions was employed, as it efficiently “exfoliates” the sample with minimal 
damage of the proximal layers of the material, and Bi3+ primary ions were used for analysis, 
reaching an approximate depth of >800 nm. Acquisition of the spectra from each layer of 
sample was recorded as a 2D image slice and the 3D image was reconstructed stacking the 2D 
images and normalizing the depth to the contour line to Z=0 (Robinson et al. 2012). 
3.15 BIODEGRADATION OF GRAPHENE OXIDE 
In order to confirm biodegradation of GO by degranulating neutrophils and purified NETs, a 
panel of techniques has been used (Kagan et al. 2010b and Farrera et al. 2014). 
3.15.1 Raman confocal microspectroscopy 
As described in section 3.13, the characteristic signature of GO with D and G band, at 1354 cm-
1 and 1582 cm-1 respectively, was analyzed over time using raman confocal microspectroscopy 
to map the different samples with a laser of 532 nm wavelength and magnification set at 600x 
(WITec alpha300 system, Germany). 10 000 spectra per sample from 3 different areas were 
averaged to display the results. The D:G ratio was also calculated as it is a measure of the 
defects introduced in the graphene structure. A reduction in the intensity of the G band indicates 
a breakdown of the carbon-carbon bonds in the graphene structure, while an increased intensity 
in the D band correlates with the introduction of asymmetry, as resulting from oxidation, for 
instance (Farrera et al. 2014). The advantage of confocal Raman microspectroscopy, over 
conventional Raman spectroscopy, is to combine the features of a confocal microscope, which 
allows to scan specific areas of the sample, with a Raman spectrophotometer that can register 
the spectra from the designated areas. This is the technique of choice in order to monitor the 
presence of graphene-based nanomaterials in biological samples, however it is quite time 
consuming and requires expertise for operating the instrument and data analysis.  
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3.15.2 Microscopy-based methods and mass spectrometry 
Complementary to Raman confocal microspectroscopy, transmission electron microscopy 
(TEM), atomic force microscopy (AFM) and matrix-assisted laser desorption/ionization 
time-of-flight mass spectrometry (MALDI-TOF MS) were used. TEM was performed 
dispensing dialyzed small and large GO flakes before and after 12 h of biodegradation onto 
TEM grids, and air-dried before analysis with a JEM-21000F JEOL TEM microscope. 
Although not returning quantitative measurements, TEM provides a qualitative assessment of 
material degradation. For AFM measurements, the samples were prepared as for TEM and 
analyzed with a Bruker Dimension Icon AFM equipped with a TESPA probe. As TEM, AFM 
can return a qualitative idea of material biodegradation, however it can also provide 
information on the number of layers and thickness of the material at atomic level, being able 
to map the surface to identify proteins associated with the graphene flakes or defects in its 
structure.  
For the specific analysis of small flakes of GO and its biodegradation products, MALDI-TOF 
MS was performed without the assistance of a matrix using a Voyager-DE PRO MALDI TOF 
mass spectrometer (AB Sciex, Framingham, MA). Mass spectrometry brings the advantage of 
monitoring the decrease of the specific peaks of the material upon degradation and the 
consequent appearance of peaks attributable to degradation products in the spectra. 
Nevertheless, analysis and interpretation of the latter part is time consuming and correlating 
the spectra of degradation products to defined chemical structures is not a trivial process. 
3.16 GENOTOXICITY (COMET ASSAY) 
To measure DNA damage induced by biodegradation products of GO on BEAS-2B cells, the 
alkaline comet assay was performed. Cells were exposed to GO degradation products for 24 h, 
then washed, harvested using trypsin and mixed with 1% low-melting point agarose at 37 °C.  
The mixture was placed on microscope slides, and the slides subjected to lysis for 1 h, then 
transferred into alkaline (pH > 13) electrophoresis buffer, and subjected to electrophoresis.   
After neutralization in Tris buffer, samples were fixed with methanol and stained with SYBR 
green. At least 100 nucleoids per sample were scored using a Leica DMLB fluorescence 
microscope. The comet assay is a technique for detecting DNA damage at a single cell level, 
presenting several advantages: besides low costs, the method is sensitive to detect low levels 
of DNA damage and requires small amount of cells per sample. The alkaline version of the 
comet assay (pH > 13) allows for the cumulative detection of DNA damage of different kinds, 
single- and double-strand breaks as well as modification of sites that result in DNA brakes in 
the alkaline milieu, as bases that underwent alkylation or oxidation. Upon electrophoresis, 
migration of the negatively charged nucleoids results in a “comet” of shorter DNA fragments 
(Tice et al. 2000). Scoring of the comets is performed with a specific software and evaluation 
can be based on the length of migration or the proportion of DNA in the tail, expressed for 
example as tail length or % DNA in tail, as in Paper IV. 
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4 RESULTS 
4.1 PAPER I: NETs HAVE IMMUNOMODULATORY EFFECTS AND ARE 
DEGRADED INTRA- AND EXTRACELLULARLY BY MACROPHAGES AND 
DENDRITIC CELLS 
 
The current research on NETs is mostly focused on the molecular signaling involved in NET 
formation and on the subsequent role of NETs in disease (Jorch and Kubes, 2017 and 
Papayannopoulos, 2018). However, much less is known about the clearance of NETs and their 
interplay with other immunocompetent cells. With this study, using a human ex vivo system 
(Farrera and Fadeel, 2013), we aimed to highlight, in a systematic and thorough way, the 
relevant response that HMDMs and MDDCs mount in response to NETs. Moreover, using the 
same model, we aimed to study which nucleases are responsible for the degradation of NET 
DNA. 
We first confirmed that NETs produced in our system bore not only a DNA scaffold, but also 
the characteristic proteinaceous components that define extracellular traps of neutrophil origin, 
like MPO and LL-37.  
The use of the cell-impermeable and DNA-intercalating dye SYTOX green was instrumental 
for the tracking of internalized NETs in both HMDMs and MDDCs without affecting 
lysosomal or cytoskeletal dynamics. With this tool, we were able to visualize internalized NETs 
in our model system and define their non-lysosomal localization, hinting that extra-lysosomal 
nucleases could be involved in the degradation of NETs. 
The expression of the lysosomal nuclease DNaseII in our model system was evaluated together 
with the expression of the ER-bound and cytosolic active TREX1 (also known as DNaseIII) 
and the extracellular nuclease DNase1L3, which is mainly produced by macrophages and DCs. 
In our model of MDDCs, DNase1L3 resulted to be prominently expressed over the other 
nucleases and in respect to the other cell types, while TREX1 seemed to be more relevant for 
the macrophage model. After successfully achieving transient downregulation of both TREX1 
and DNaseII in HMDMs, we could observe that TREX1-deficient HMDMs were not proficient 
in degrading internalized NETs, while downregulation of DNaseII was not affecting the 
process. Furthermore, concomitant silencing of both DNaseII and TREX1 lead to similar 
results as the TREX1 deficient scenario, thus confirming that TREX1, but not DNaseII is 
responsible for NET degradation in HMDMs. Next, we showed that MDDCs were indeed 
capable of releasing DNase1L3 both constitutively and, to a greater extent, in response to the 
NET stimuli. Secreted DNase1L3 was capable of dismantling NETs in a time-dependent way 
and downregulation of this nuclease resulted in minor effectiveness in degradation of the 
extracellular traps. 
Taking into consideration that a variety of experimental models and conditions have been to 
date used with the aim to describe interactions between NETs and other immune cells, we 
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sought to use our human ex vivo model for the purpose to compile a systematic overview of 
the response that HMDMs and MDDCs mount when exposed to NETs. Our study revealed that 
NETs induce morphological changes in both cell types, with a dramatic modulation of the 
phenotype of MDDCs, which however does not result in activation or maturation, as per 
expression of the surface markers CD80, CD83 and CD86. Moreover, when considering 
co-stimulation with LPS, NETs were markedly able to reduce the effect of endotoxin stimuli 
to levels comparable to exposure to NETs alone. 
The immunomodulatory potential of NETs was confirmed by the analysis of cytokines, 
chemokines and growth factors secreted by MDDCs and HMDMs in response to NETs and 
LPS. Exposure of both cell types to the traps did not elicit a remarkable production of cytokines, 
while co-exposure with endotoxin modulated the effects of the latter on the cells. Co-exposure 
to NETs and LPS triggered significant production of IL-1β by both cell types, hinting at 
inflammasome activation, whereas reducing LPS-activated secretion of the 
immunomodulatory cytokine IL-10 and of the T-cell stimulatory molecule IL-12. NETs were 
capable of inducing secretion of the neutrophil chemoattractant IL-8 (CXCL8) as well as 
MIP-1α (CCL3) and MIP-1β (CCL4) by both MDDCs and HMDMs. Furthermore NETs 
reduced the endotoxin-mediated release of IP-10 (CXCL10) by MDDCs and abolished it in 
HMDMs. Concomitant exposure to NETs and LPS triggered the release of G-CSF and 
GM-CSF by HMDMs and G-CSF by MDDC, conversely, NETs abolished the LPS-mediated 
release of VEGF by both cell types. Overall, NETs appear to have specific modulatory effects 
on macrophages and DCs. 
As summarized in Figure 4, these findings shed light on the mechanisms of intra- and 
extracellular NET disposal, and provide a systematic overview of the immunomodulatory 
effects of NETs on LPS-activated macrophages and DCs. 
 
Figure 4: Schematic summary of the findings in Paper I.  
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4.2 PAPER II: MYELOPEROXIDASE-MEDIATED FUNGAL KILLING IN NETs 
REQUIRES JAGN1: IMPLICATIONS FOR SEVERE CONGENITAL 
NEUTROPENIA 
 
NETs are believed to be required for efficient fungal killing, including the killing of the 
clinically relevant Candida albicans (Urban et al. 2006). 
Homozygous mutations in JAGN1 have been recently reported to be at the base of SCN in 
humans (Botzug et al. 2014), and the deletion of Jagn1 in the hematopoietic lineage of mice 
highlighted that counteraction of C.albicans infection by neutrophils in those individuals was 
ineffective (Wirnsberger et al. 2014).  
In this work, we were able to sample neutrophils from a SCN patient with JAGN1 mutations 
and were able to detect NET formation, irrespectively of the genetic defect. However, both 
NETs and neutrophils from the patient displayed lower levels of MPO in relation to the healthy 
control.  
Next, we established an in vitro model, using the hematopoietically relevant cell line HL-60, 
in which JAGN1 was transiently downregulated, and could confirm in this model that the 
production of NETs was not affected by JAGN1 deficiency, although the presence of MPO on 
NETs was visibly lower compared to the control. Furthermore, overexpression of JAGN1 in 
the same model resulted in a recovery of the NET phenotype. Downregulation of JAGN1 in 
HL-60 did not interfere with the process of differentiation into neutrophil-like cells, as per 
CD11b expression and nuclear morphology variation, while affecting MPO expression at both 
transcript and protein level. 
The current therapy for SCN is administration G-CSF, which restores a normal neutrophil 
count, yet the functionality of the circulating neutrophils seems not to be optimal in respect to 
the defense against microorganisms (Donini et al. 2007). Additionally, administration of 
GM-CSF, but not G-CSF, has been shown to recover the impairment in killing of C.albicans 
by Jagn1 deficient mice (Wirnsberger et al. 2014). We therefore sought to investigate the role 
of GM-CSF in our in vitro model, and we showed that pre-treatment of HL-60 cells transfected 
with specific JAGN1 siRNA could recover both the MPO presence on NETs and restore MPO 
expression in the cells. 
Ultimately, we studied the performance of NETs, purified from HL-60 transfected with JAGN1 
siRNA or control siRNA, in killing of C.albicans in both yeast and hyphae form. Using two 
different assays to determine fungal growth, we could observe that both yeast and hyphae 
exposed to NETs from JAGN1 deficient HL-60 cells were proliferating to a greater extent 
compared to the fungi exposed to NETs purified from control HL-60. Administration of 
GM-CSF to the cells prior to NETs purification recovered killing capacity of NETs from HL-60 
cells with reduced expression of JAGN1 to an extent comparable to control NETs. Moreover, 
as we pinpointed that the defect in NETs from JAGN1 deficient cells is in the MPO decoration 
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of the traps, we added purified human MPO to the system, which restored the killing capacity 
of those NETs. 
In conclusion, the present study illustrates how JAGN1 deficiency is reflecting into an impaired 
functionality of NETs resulting in a compromised MPO-mediated killing of fungi within the 
traps. In addition, we could elucidate how GM-CSF restores both phenotype and function on 
NETs in our JAGN1 deficient HL-60 model, suggestive of future directions to be considered 
in the therapy of JAGN1-dependent SCN. 
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4.3 PAPER III: GRAPHENE OXIDE PERTURBATES LIPID HOMEOSTASIS IN 
THE PLASMA MEMBRANE OF NEUTROPHILS AND TRIGGERS 
SIZE-DEPENDENT FORMATION OF EXTRACELLULAR TRAPS 
 
Graphene Oxide (GO) is a two-dimensional nanomaterial currently gaining tremendous 
attention for its physicochemical properties that render it potentially suitable for a variety of 
applications, including biomedical use for clinical imaging and drug delivery (Yang et al. 
2013). While several reports have focused on macrophage interacting with GO, there are no 
studies on the interactions of GO with neutrophils. In the present study we investigated the 
impact of GO of different sizes on neutrophils and the interactions that GO entertains with the 
lipids in the plasma membrane of these cells. 
First, thorough characterization of the material was carried out, highlighting that small and 
large flakes of GO used in the study differed only for the lateral dimension, maintaining other 
properties constant. In addition, assessment of endotoxin contamination showed that the 
material was endotoxin-free, thus the effects displayed on cells were to be related to the 
intrinsic properties of the material. 
In order to determine cell viability of neutrophils exposed to GO, we performed dose-response 
studies, which showed that cell survival at 3 h was maintained up to 80% at the lower doses. 
Next, we assessed NET production and could detect formation of extracellular traps by 
neutrophils exposed both to small and large flakes, with the large flakes inducing NET 
formation to a greater extent.  
We then explored mechanisms of NET formation induced by GO and used MβCD, known 
cholesterol-depleting agent able to trigger NADPH oxidase-independent NET formation 
(Neumann et al. 2014a), for comparison. As expected, NET production triggered by PMA was 
blocked by inhibition of NADPH-oxidase, while MβCD mediated NET formation was not. 
Large GO flakes did also induce NET production independently of NADPH-oxidase, while 
small flakes required it. Furthermore, we studied the role of mitochondrial ROS and calcium 
in GO-triggered release of NETs and could observe calcium influx mediated by large flakes 
together with mitochondrial reactive oxygen species production. As the release of NETs was 
suppressed by both calcium chelation and mitochondrial ROS inhibition, we could show that 
the mechanism of NET production triggered by large GO flakes is dependent on calcium and 
reactive oxygen species of mitochondrial origin. 
As we noticed similarities between the behavior of MβCD and large GO, and saw that GO was 
interfacing with the plasma membrane of neutrophils by TEM imaging, we proceeded to look 
at lipid perturbations in the plasma membrane elicited by GO. To this aim, we analyzed lipid 
rafts stability using CTXB staining and filipin III staining for cholesterol, and showed that large 
GO flakes induced lipid raft disruption and cholesterol depletion in the plasma membrane of 
neutrophils, in analogy with MβCD treatment. With the use of ToF-SIMS we were able to 
characterize modifications of lipids in the plasma membrane of neutrophils exposed to large 
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GO flakes and we could show that GO elicited a reduction in cholesterol, but augmented the 
presence of oxidized cholesterol species, therefore, we asked whether GO was capable of 
directly oxidizing cholesterol in the plasma membrane. To this purpose, after confirming the 
presence of single carbon radicals on GO via EPR analysis, we showed that GO was indeed 
capable of directly oxidizing a model probe, while no direct oxidation of cholesterol was 
detected in an acellular model system, suggesting that cholesterol oxidation by GO requires 
multiple steps and players. 
Last, we asked whether inhibition of cholesterol oxidation in the plasma membrane would 
prevent membrane perturbation and the subsequent release of NETs in neutrophils exposed to 
GO. In order to address this question, the vitamin E analog bearing antioxidant properties, 
Trolox, was pre-incubated with neutrophils, which were then exposed to GO. Indeed, the use 
of Trolox reduced both cholesterol oxidation and production of extracellular traps by 
neutrophils exposed to large GO flakes. 
With this study, we were able to describe the outcome of the interaction between neutrophils 
and GO, and define the mechanism of NET formation related to the exposure. Furthermore, 
the use of ToF-SIMS to analyze cell surfaces allowed detailed lipid analysis of the biological 
specimen, highlighting the usefulness of this technique for investigating biological material. 
Taken together, the findings in this study describe not only toxicity mechanisms of GO on 
neutrophils, but also suggest a way to scavenge the adverse outcome that can potentially arise. 
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4.4 PAPER IV: GRAPHENE OXIDE BIODEGRADED BY NEUTROPHILS IS NOT 
GENOTOXIC FOR LUNG CELLS: IMPLICATIONS FOR RISK ASSESSMENT 
 
One caveat that has to be considered regarding the use of engineered nanomaterials in 
medically relevant employment is their persistency in the body, after fulfillment of their 
function. It is to date well understood that biopersistency in the lungs of asbestos-like materials 
is cause of granuloma, and ultimately cancer and loss of functionality. It has been shown 
previously that single walled carbon nanotubes, a graphene-based material, can be degraded in 
vivo and in vitro by neutrophil myeloperoxidase (MPO) (Farrera et al. 2014 and Kagan et al. 
2010b). In this paper, we investigated whether GO could be degraded by neutrophils and 
whether the degradation products would bear genotoxic side effects. 
For the present study, the same GO, with two different lateral dimensions used in Paper III, 
was analyzed. Size distribution of the materials was defined and endotoxin contamination was 
excluded. 
Degradation of GO flakes was first carried out in an acellular system, where GO was incubated 
with purified human MPO together with NaCl and H2O2, relevant substrates for the enzymatic 
catalysis, in the presence or absence of MPO inhibitor I. Over a 12 h period of time, the GO 
signature, as per the characteristic D-band and G-band on the Raman spectrum, was completely 
removed by MPO treatment, while in the presence of the specific MPO inhibitor the intensity 
of D-band and G-band remained unvaried, confirming that the biodegradation process is 
myeloperoxidase-dependent. Moreover, compiling the D:G ratio, a measure of the defects 
introduced in the pristine structure of graphene, and confirming our observation using atomic 
force microscopy, we showed that MPO-mediated degradation was proceeding over time for 
both small and large flakes. 
Neutrophils are known to engage both intracellular and extracellular strategies in order to 
counteract infections, hence, in the present study, we focused on degranulation and formation 
of extracellular traps as the means that neutrophils could exploit to degrade GO.  To this end, 
degranulation was triggered in freshly isolated primary human neutrophils and exposure to 
small or large GO flakes was carried out up to 6 h. For GO flakes of both sizes, we could 
observe a time-dependent reduction in the GO specific signature in the Raman spectra, 
indicating that degradation was progressing over time. Additionally, NET production was 
triggered in freshly isolated neutrophils, purified NETs were collected and co-incubated with 
GO, together with the relevant substrates for MPO activity, in an acellular system up to 12 h. 
Confocal Raman analysis confirmed biodegradation of the material, which was completely 
constrained by the addition of MPO inhibitor I. 
Toxicity of intermediate biodegradation products obtained from degradation of small and large 
GO flakes with purified MPO was tested on the epithelial lung cell line BEAS-2B, as this is a 
relevant model to study carcinogenesis related to inhalation exposure. Cell viability and 
genotoxicity, which was studied using the comet assay for evaluation of DNA damage, were 
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assessed after 24 h exposure to biodegradation products obtained at different time points, in 
order to assess toxicity of various digestion intermediates. Cell viability was maintained upon 
exposure to the different GO products and DNA damage elicited by the pristine materials as 
well as by degradation products was comparable to control levels for both small and large 
flakes. 
In summary, this study shows that neutrophils can mediate degradation of GO in the 
extracellular environment in a MPO-dependent manner and that the resulting intermediate 
products do not reduce cell viability nor induce DNA damage in lung epithelial cells. These 
findings may be relevant for the risk assessment of these materials for human health, as they 
suggest that inhalation exposure to GO would not pose a carcinogenic risk, provided that the 
degradation of the material occurs. 
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5 DISCUSSION 
5.1 ORCHESTRATED CLEARANCE OF NETs 
To date, much of the literature on NETs has been focused on describing mechanisms of NET 
formation and pathogen killing. Only in recent years, the interest in mechanisms of NET 
clearance has grown. Investigating how NETs are disposed of is not a trivial process. First, 
protocols used to separate NETs from neutrophils or neutrophil debris vary amongst different 
studies, implying that what is defined as “NETs”, “purified NETs” or “isolated NETs” presents 
inter-study variability that can lead to contrasting results. On the other hand, no “perfect 
protocol” that yields pure NETs, as defined per a DNA backbone decorated with a specific 
panel of proteins, without any other contaminant, has been established. A way-out to this issue 
could be the use of purified DNA artificially complexed with proteins or peptides of interest, 
but the lipid or sugar component of NETs, which is to date yet to be studied, and the complexity 
of the NET structure would be lost. Second, conditions for extracellular degradation with serum 
nucleases, as DNaseI, might be easier to control, as, in principle, separation from the 
neutrophils would not be necessary, or easier to replicate in test-tube experiments compared to 
studying intracellular degradation within the phagocytes. To this end, a NET-specific labeling 
tool, which should not interfere with either degradation or enhance cellular uptake, would be 
of great help in monitoring the intracellular journey of the traps. For the work in this thesis, 
isolation of NETs was aimed mainly to obtain a preparation that would exclude whole cells 
and cell debris, while labeling of the NETs, when incubated with mononuclear phagocytes,  
was carried out with a DNA dye as the point of interest was the tracking of the DNA component 
of the traps inside the phagocytes.  
The fact that various intra- and extracellular nucleases are arrayed to minimize the risk of 
inadvertent immune responses triggered by self-DNA, highlights the importance of these 
mechanisms, underlined also by the evidence that mutations in such enzymes are linked with 
autoimmune SLE (Yasutomo et al. 2001, Lee-Kirsh et al. 2007 and Al-Mayouf et al. 2011). 
While the capacity of DNaseI in degrading NETs and factors inhibiting this process, as 
autoantibodies and C1q (Hakkim et al. 2010 and Leffler et al. 2012), have been studied, not 
much is known about other nucleases nor intracellular degradation (Farrera and Fadeel, 2013).  
DNAse1L3, also known as DNaseγ, was first implicated in internucleosomal DNA 
fragmentation in necrotic and apoptotic cells (Mizuta et al. 2013 and Errami et al. 2013) and 
lymphoma cell lines deficient in DNAse1L3 expression were described as apoptotic-resistant 
(Boulares et al. 2006). In their recent work, Sisirak and colleagues showed that DNase1L3 was 
produced by human and murine mononuclear phagocytes and was able to prevent the 
development of SLE phenotype by digesting DNA associated with apoptotic macrovesicles 
(Sisirak et al. 2016), but no correlation with NET DNA was reported. In a mouse model, sera 
from Dnase1l3-/- mice and DnaseI-/- mice showed no impairment in degrading NETs, while the 
double knock-out was ineffective, suggesting that the two nucleases might be exchangeable 
and compensate each other (Jiménez-Alcázar et al. 2017). Conversely, a comparison between 
the activity of DnaseI and Dnase1l3 suggested a higher propensity of the latter to proficiently 
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process chromatin at an internucleosomal level, while the degradation by DnaseI had a random 
pattern (Napirei et al. 2005). In paper I, we confirmed that human DNase1L3 is capable of 
degrading NET DNA and it is secreted by MDDCs both constitutively and, to a greater extent, 
in response to NETs. Moreover, considering our observation on DNase1L3 localizing both in 
the nucleus and in the cytoplasm of DCs, as well as the known sequence of the protein, which 
contains nuclear localization domains (Shiokawa et al. 2003), one can speculate that two 
isoforms of the protein coexist, being involved in chromatin fragmentation during apoptosis 
(nuclear pool) or secreted and consequently involved in extracellular DNA fragmentation. 
Although the link between mutations or deficiency of TREX1 and SLE or IFN signature has 
been made, not much is known regarding endogenous substrates of TREX1. A couple of studies 
in mouse models hypothesized that endogenous retroelements could be processed by Trex1 
and impairment in this process would lead to a sustained production of interferons, however 
opposing findings were disclosed (Stetson et al. 2008 and Achleitner et al. 2017). Gehrke et al. 
observed that oxidized DNA is resistant to degradation by TREX1 and that DNA purified from 
NETs presents a relevant degree of oxidative damage, thus conferring hindrance to degradation 
(Gehrke et al. 2013). The preparation described as “purified NETs” in Paper I refers to 
“pristine” NETs, which were not subjected to DNA extraction or purification, as oxidative 
damage can occur when DNA purification methods are used (Costello et al. 2013), and allowed 
us to unravel a role for TREX1 in degradation of NET DNA in HMDMs. In our model system, 
we observed that NETs internalized by macrophages were not co-localizing with the 
lysosomes, thus potentially justifying a role for the non-lysosomal activity of TREX1 in the 
intracellular degradation process. Interestingly, LL-37 in complex with genomic DNA was 
reported to be capable of shuttling the nucleic acid through the plasma membrane into the 
cytosol of mammalian cells (Chamilos et al. 2012) and synovial fibroblasts were found to 
internalize NETs in a RAGE-TLR9 dependent mechanism without the involvement of actin 
and cytoskeleton reorganization (Carmona-Rivera et al. 2017). In this scenario, it is intriguing 
to think that NETs could possibly be “transfected” through the plasma membrane in a LL-37 
dependent manner. 
The study in Paper I provides new insights into the strategies that macrophages and DCs utilize 
to dismantle NETs and describes two nucleases involved in the process. These findings broaden 
the currently limited knowledge on the mechanisms of NET degradation and suggest new lines 
of scientific investigation with potential clinical relevance regarding impaired mechanisms of 
NET disposal in autoimmune diseases. 
5.2 IMMUNOMODULATORY EFFECT OF NETs 
Cell death can occur in different flavors, each one of them tuning the surrounding 
microenvironment to respond accordingly. While the immunological consequences of 
apoptotic cell death have been intensively studied (Hochreiter-Hufford and Ravichandran, 
2013 and Gordon and Plüddemann, 2018), very little is known about the effects of NETs 
released by dying neutrophils on other immune cells. On one hand, macrophages exposed to 
NETting neutrophils, activated with pathogens or PMA, were capable to release 
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pro-inflammatory mediators and were ultimately undergoing cell death (Nakazawa et al. 2015 
and Braian et al. 2013). On the other hand, Farrera and Fadeel described the response of 
macrophages to engulfed NETs as “silent” based on the observation that NETs alone were not 
able to trigger relevant production of soluble mediators (Farrera and Fadeel, 2013). Here we 
confirmed that, for the majority of the soluble mediators taken into account, this still holds true. 
However, we noticed, amongst other chemokines, a remarkable release of IL-8 by both 
HMDMs and MDDCs, pointing at the fact that the traps represent a signal to other immune 
cells. Original findings showed that NETs offer a platform for degradation of pro-inflammatory 
cytokines, as IL-1β or TNF, and chemoattractive factors for macrophages, eventually limiting 
inflammation (Schauer et al. 2014). Conversely, NETs were found to promote IL-1β release 
by macrophages in combination with cholesterol crystals or LPS, and that this effect was more 
pronounced in lupus macrophages (Warnatsch et al. 2015, Hu et al. 2017, and Khalenberg et 
al. 2013). In Paper I, we confirmed that IL-1β was secreted by HMDMs in response to NETs 
in co-exposure with LPS and that MDDCs responded to this co-stimulation in the same way. 
Similarly, we found that NETs were relevant in modulating the effects of LPS in both HMDMs 
and MDDCs, reducing LPS-triggered release of IL-10 and IL-12 by both cell types. 
Furthermore, we confirmed the findings by Barrientos et al. that described NETs reducing 
LPS-triggered activation of DCs in terms of both maturation markers on the surface and 
cytokine production (Barrientos et al. 2014). Of note, NETs from mice with collagen-induced 
arthritis or from patients with RA were capable of activating DCs from a healthy counterpart 
(Papadaki et al. 2016) while NETs from healthy donors were not effective (Barrientos et al. 
2014). Besides their role in mounting an inflammatory response, macrophages play a great part 
in the resolution of inflammation and tissue regeneration. In this context, it was interesting to 
observe how NETs could abolish LPS-mediated release of VEGF by both HMDMs and 
MDDCs. In contrast with clearance of apoptotic cells, which induced VEGF release by 
macrophages that in turn promoted proliferation of neighbouring endothelial cells (Golpon et 
al. 2004), NETs were reportedly responsible to induce profound damage at endothelial level 
(Villanueva et al. 2011 and Kolaczkowska et al. 2015). Our observation that NETs affect LPS 
signalling in tissue regeneration gives an interesting insight and room for new studies to address 
how NETs might dysregulate tissue repair processes in infectious conditions. 
Observations that NETs per se seemed not to affect other immune mechanisms might have led 
to a limited interest investigating their immunostimulatory potential, however, in light of the 
findings discussed above, a new line of research considering the immunomodulatory effects of 
NETs in combination with other stimuli might be more relevant to understand both pathological 
and physiological processes. 
5.3 JAGN1 IN NET-MEDIATED KILLING OF FUNGI 
Homozygous mutations in JAGN1 are reportedly causative of SCN and JAGN1 mutations seem 
to affect the functionality of the protein. Although a role for jagunal has been described in the 
oogenesis of Drosophila melanogaster (Lee and Cooley, 2007), a precise function for the 
human homolog remains to be defined. SCN patients bearing mutations in this gene display an 
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aberrant glycosylation pattern of proteins processed by the ER (Botzug et al. 2014) and mice 
deficient for the protein in the hematopoietic lineage display high susceptibility to fungal 
infection by C. albicans, as well as lower levels of MPO (Wirnsberger et al. 2014). Of note, 
the MPO precursor protein undergoes N-glycosylation (Hansson and al. 2006), however in the 
study presented in Paper II, no evidence of altered glycosylation patterns of MPO were 
discovered when JAGN1 was silenced in HL-60 cells or in neutrophils from SCN patients with 
mutated JAGN1. 
NETs account for about one third of the ability of neutrophils to counteract fungal infections 
(Urban et al. 2006), in particular regarding the hyphae form (Branzk et al. 2014). Besides 
capturing the pathogens within their webs, the extracellular traps are endowed with an array of 
microbicide weapons, of which MPO is of paramount relevance in counteracting C. albicans 
infections (Lehrer et al. 1969). Furthermore, MPO seems to be necessary for NET production 
(Metzler et al. 2014) and individuals lacking MPO were found to be unable to release NETs. 
However, individuals that presented only a partial deficiency in MPO were still capable of 
producing NETs (Metzler et al. 2011). In Paper II we confirmed a reduction of MPO levels in 
a SCN patient bearing JAGN1 mutations and, similarly, JAGN1 deficient HL-60 cells 
displayed lower levels of MPO transcripts and protein. Both the SCN patient and JAGN1 
deficient neutrophil-like cells were capable of producing NETs, yet, while the DNA content 
was similar in the presence or absence of JAGN1, MPO on NETs was less abundant compared 
to the respective controls. Assessing the fungicidal potential of NETs in our model, we 
observed that NETs from JAGN1 deficient HL-60 cells were less efficient in counteracting 
Candida growth and that this defect was rescued by addition of purified MPO or by pre-
incubation of the cells with GM-CSF. The current therapy for SCN is administration of G-CSF, 
which restores a physiological number of neutrophils in the circulation. Albeit reestablishing 
the neutrophil count, the current therapy does not recover full functionality of the cells. Donini 
et al. showed that SCN patients conserve low MPO levels despite the therapy and, even though 
the molecular machineries involved in phagocytosis are intact, they display an impaired ability 
to kill C. albicans (Donini et al. 2007). These results were confirmed in a transgenic mouse 
model, in which G-CSF treatment was compared to GM-CSF. Indeed, the use of GM-CSF was 
able to not only increase MPO levels, but also to prolong life expectancy reducing susceptibility 
to C. albicans infection in the mouse model (Wirnsberger et al. 2014). Taken together, these 
findings show that JAGN1 is not necessary for NET release as such, but is required for their 
functionality as it regulates MPO levels on the traps. Furthermore, recovering the defects 
induced by JAGN1 deficiency, GM-CSF administration seems to be a promising alternative 
for SCN patients that poorly respond to G-CSF, but further research is due in this respect. Also, 
we could show that JAGN1 influences MPO abundance in SCN neutrophils and HL-60 
neutrophil-like cells, however whether this is an MPO-specific effect or a broader effect on 
other granule proteins and which are the exact mechanisms regulating the process, remains to 
be revealed. 
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5.4 GO-INDUCED PRODUCTION OF NETs 
To date, many studies have addressed the outcomes of interactions between graphene-based 
nanomaterials and immunocompetent cells (Mukherjee et al. 2017), yet reports on how 
neutrophils interact with these kind of materials are lacking. A couple of studies have claimed 
that neutrophils can release extracellular traps in response to either gold nanorods or cationic 
solid lipids (Bartneck et al. 2009 and Hwang et al. 2015), yet the supporting evidence was 
rather weak, whereas Liz et al. convincingly showed that neutrophil responded to silver 
nanoparticles with ROS production and NET release (Liz et al. 2015). Regarding 
graphene-based materials, nanodiamonds were able to induce NET production (Muñoz et al. 
2016), while SWCNTs were not proficient in triggering NET release (Farrera et al. 2014), 
however no studies have previously investigated the effects of GO on neutrophils.  
In Paper III, we describe that GO of different lateral dimensions elicits NET production in a 
size-dependent manner, with the small GO flakes being less effective in triggering the process. 
In addition, we showed that small GO flakes require the action of NADPH oxidase to trigger 
ROS-dependent NET release, while inhibition of NADPH oxidase did not affect NET 
production by the large flakes. As mitochondrial ROS can be a downstream event of calcium 
influx and ultimately lead to NET release, we compared GO with a calcium ionophore, as these 
kind of trigger elicit NET formation in mitochondrial ROS-dependent way (Douda et al. 2015), 
and observed that GO promoted calcium influx and mitochondrial ROS production, ultimately 
leading to the release of NETs. 
It has been repeatedly reported that different stimuli can result in NET release through distinct 
mechanisms, which can involve NADPH oxidase or not (Parker et al. 2012b and Kenny et al. 
2017). As we observed close interaction between GO, especially the large flakes, and the 
plasma membrane of neutrophils, we compared, at the plasma membrane level, the effects of 
GO with MβCD, a cholesterol-depleting agent able to induce NET release without the 
involvement of NADPH oxidase (Neumann et al 2014a). In both cases, we observed disruption 
of lipid rafts and decided to use ToF-SIMS in order to analyze changes in lipids at the cell 
membrane on a surface level as well as in depth into the membrane (Brison et al. 2011). A 
general decrease in cholesterol and a rise in oxidized cholesterol species was detected upon 
exposure to GO. 7-ketocholesterol, a derivate of cholesterol resulting mainly from 
non-enzymatic oxidation (Girotti, 1998), was predominately found in GO-exposed cells and 
could be responsible for the lipid raft disruption observed, as it reduces organization of 
phospholipid membranes compared to cholesterol (Massey and Pownall, 2005). We also 
observed that GO was not directly oxidizing cholesterol, implying that a more complex process 
involving also cellular components might be required, as shown in the schematic in Figure 5, 
and that administration of a vitamin E analog as antioxidant could prevent both cholesterol 
oxidation and NET production. These observations suggest that the harmful effects of the 
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material can be limited and properly controlled, making it a promising candidate for biomedical 
use. 
 
Figure 5: Proposed mechanism of multi-step non-enzymatic cholesterol oxidation by carbon 
radicals on GO. PUFA: polyunsaturated fatty acids. Reproduced from Mukherjee et al. 2018, 
Chem. 4: 334-358. 
Descriptions of GO nanosheets forming pores and causing ruffling and shedding of plasma 
membrane in mammalian cells, ultimately affecting cell adhesion or viability (Duan et al. 2017 
and Sun et al. 2016) have been reported. In that cases, the suggested mechanism of action was 
mechanical interaction or lipid extraction from the membranes, supported by molecular 
modeling. Conversely in Paper III, we showed that the material is chemically active in 
perturbing the membrane, although other kinds of interactions cannot be ruled out.  
Mukherjee et al. report experimental evidence, supported by in silico simulations, that sensing 
of endotoxin-free SWCNTs, but not GO, by macrophages is mediated by TLR2 and TLR4 
(Mukherjee et al. 2018b). Indeed, in the present study, GO was shown to chemically modify 
lipids in the cell membrane of neutrophils, ultimately triggering NETs, possibly excluding the 
need for a receptor-mediated mode of action. Similarly, it has been illustrated that both the 
adjuvant alum and uric acid crystals could elicit effects on DCs by altering lipid homeostasis 
of the plasma membrane (Flach et al. 2011 and Ng et al. 2008). Taken together, these findings 
suggest that GO could modulate responses of innate immune cells through different effects on 
lipids of plasma membrane. 
5.5 IMPORTANCE OF BIODEGRADATION OF GO 
In Paper IV, the same small and large flakes of GO used in Paper III were taken into account 
for testing their susceptibility to biodegradation by neutrophils. Previous studies demonstrated 
biodegradation of oxidized SWCNTs by neutrophils both in vitro and in vivo (Kagan et al. 
2010b) as well as that biodegradation could occur within NETs in a MPO-dependent fashion 
(Farrera et al. 2014).  Indeed, MPO was responsible also for biodegradation of GO and, using 
AFM, we could show that the protein was attaching directly on the surface of the material.  
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While several biological effects of graphene-based nanomaterials have been reported, a lack of 
information is still present regarding the effects of degradation products originating from these 
materials. Taking into account that peroxidase-mediated degradation of SWCNTs can proceed 
to the extent of yielding CO2 and water, intermediate degradation products might present 
structures comparable to oxidized polycyclic aromatic hydrocarbons (PAHs) (Allen et al. 2009 
and Kagan et al. 2010b). Although intermediate products obtained by MPO-mediated 
degradation of SWCNTs seemed to induce a greater impairment in cell viability of neutrophils, 
compared to cells exposed to the same amount of pristine material (Farrera et al. 2014), 
intermediate degradation products of GO did not impair viability of BEAS-2B cells. In the case 
of GO, which could directly trigger NET formation, assessing toxicity of degradation products 
on neutrophils might not be ultimately relevant for an in vivo exposure scenario, as GO-induced 
NET release can ultimately result in the death of PMNs producing the NETs. Therefore, 
assessing toxicity on BEAS-2B cells might be of higher interest considering a scenario in which 
inhalation exposure occurs, followed by neutrophil infiltration and in loco GO degradation. Of 
note, after 24 hours from exposure, GO seemed to increase metabolic activity of the cells, 
which could hint to mechanisms involved in longer-term toxicity. At the same time point, 
degradation products did not produce DNA damage either, contrasting with former studies 
indicating DNA fragmentation and chromosomal aberration in spermatozoa of mice, however 
these effects were consequent to administration of high doses (2000 µg/mL) or repeated 
exposure to GO (Akhavan et al. 2015). 
Prompt and fast, within hours from exposure, degradation of GO are desirable qualities for the 
use of this material as drug carrier or for diagnostic purposes, limiting the risk of biopersistence. 
Moreover, absence of DNA damage by degradation products is also a promising feature; 
however, a thorough characterization of the compounds in the degradation mixture is due and 
needed, being helpful to design further experiments to investigate different endpoints of 
toxicity.  
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6 GENERAL CONCLUSIONS AND OUTLOOK 
 
The work herein presented highlights the complex and multifaceted aspects of neutrophil 
extracellular traps (NETs), from their “birth”, throughout their “active age” to their “death”. In 
the present section, general conclusions are drawn and some reflections for future work are 
presented. 
Versatility is the key. Release of extracellular traps occurs in response to a variety of stimuli: 
self or altered-self objects, and non-self entities. From the findings in this thesis, it is possible 
to conclude that neutrophils are induced to release NETs in response to conventional 
pathogens, as fungi, and non-conventional foreign objects, as two-dimensional nanomaterials. 
Even though the specific pathways involved in the release of the traps may vary, we were able 
to show that, in both circumstances, the ultimate function of NETs is dismantling the foreign 
object to prevent harmful outcomes. Notably, but not surprisingly, we could demonstrate the 
enzymatic oxidative activity of MPO, which is maintained on NETs, is a common key element 
in both counteracting fungal infections and degrading 2D-nanomaterials, corroborating the idea 
that the innate immune system can efficiently handle a variety of items using identical 
strategies. 
Non-conventional problems require non-conventional solutions. Investigating the interactions 
of a two-dimensional nanomaterial with a biological system might seem, at first, an exercise in 
futility, however the increasing industrial use of these materials rises the risk of exposure and 
their desirable properties useful in medical applications deserve to be exploited in a safe 
manner. Analyzing the interactions between the material and the biological system requires the 
use of techniques that are not routinely employed in molecular biology, thus challenging to 
adapt them to the biological substrate. In this thesis, we could show that a combination of 
conventional assays and ToF-SIMS imaging complemented each other in describing a novel 
mechanism of NET formation in response to an “unconventional pathogen” acting on 
disruption of plasma membrane homeostasis instead of on a ligand-receptor base. This kind of 
approach, bringing together very different expertise, would be definitely useful also in 
“conventional” research, as observing a phenomenon from a different point of view would 
enrich the knowledge of it. Moreover, a thoroughly characterized nanomaterial, which interacts 
with the biological system in the same size range, can represent a useful tool to understand the 
behavior of nanosized entities in living organisms. 
In the right place and at the right time. Impairment in the clearance of NETs from the 
extracellular milieu is tightly connected with their role in the onset of an autoimmune response, 
therefore it is not unexpected that more than one mechanism, possibly complementing each 
other, need to be arrayed to degrade the traps. Here we could show that mononuclear 
phagocytes arrange both intracellular and extracellular nucleases to the scope, with 
macrophages, being professional phagocytes, degrading the traps intracellularly through the 
action of TREX1, and DCs contributing to the extracellular degradation through DNase1L3. 
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Brinkmann and Zychlinsky ask whether immunity would be the second function of chromatin 
(Brinkmann and Zychlinsky, 2012). Indeed, we could show that NETs present 
immunomodulatory capacity, tuning the activation and the release of soluble mediators by 
macrophages and DCs in response to LPS. Considering that NETs can modulate the action of 
other immune cells in an infectious condition, but they need to be removed in order to 
circumvent an aberrant autoimmune response, it would be of interest to assess which is the time 
frame that harbors only beneficial properties of NETs, in other words, their useful lifespan, in 
order to exploit and modulate their function in counteracting infections. Another point of 
interest, to date not much studied, is the ability of peptides and opsonizing factors, as C1q or 
immunoglobulins, to hinder nucleases-dependent degradation of the extracellular traps. It has 
been reported that graphene based nanomaterials of interest for gene delivery, when in complex 
with nucleic acids, prevent the degradation of the latter. As we reported that graphene oxide is 
able to trigger relevant NET production, it would be of interest to include engineered 
nanomaterials in the panel of factors to investigate when studying inhibition of NET 
degradation. 
Of mice and men. Soon after NETs were discovered, the scientific community started 
questioning whether NETs visualized in vitro were representing an event reflecting an in vivo 
behavior, or were just a beautiful artifact. Reports that extracellular DNA structures could be 
found in biopsies from humans or live tissue imaging of rodents, suggested that production of 
extracellular traps could happen in living organisms, however the relevance of this 
phenomenon in mice and men might largely differ. The susceptibility to infecting 
microorganism is quite different in the two species and, accounting for up to 70% of total 
circulating leukocytes in human, neutrophils represent only up to 25% of the white blood cells 
in mice (Mestas and Huges, 2004), suggesting that mechanisms other than NET release might 
be more relevant to counteract infections. An interesting model to study defects in NET 
production or clearance is the human ex vivo model, largely employed in this thesis. Particularly 
interesting to study NET dynamics, co-cultures of primary human immune cells exposed to 
NETs, together with other relevant stimuli or pathogens, could yield a simplified, yet 
representative and relevant model. Furthermore, studies using primary neutrophils from 
patients with defined genetic defects, as patients with chronic granulomatosus disease or 
bearing MPO deficiencies, have to date provided solid evidences in describing mechanisms of 
NET formation. Likewise, primary mononuclear phagocytes from patients with mutations in 
nucleases, as TREX1 or DNase1L3, or defects in vesicular trafficking linked to phagocytosis 
processes, could be used to investigate in deeper detail how intra- and extracellular disposal of 
NETs occurs in the human organism.  
To eat or not to eat. To date, a few studies were able to show that NETs are internalized by 
other immune competent cells, however the mechanisms through which this is achieved remain 
mostly on a speculative level. Thorough characterization of NET composition, including lipids 
and carbohydrates, can hint to the components that might act as “eat me” signals for the 
phagocytes, thus indicating which receptors could be involved. On the other hand, the 
internalization process might not require a receptor-ligand mechanism at all, hence a 
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physicochemical characterization of the “NET-particles” could nevertheless pinpoint which 
components would allow the “transfection” process. 
The work presented in this thesis wants to encourage an interdisciplinary approach in the 
investigation of neutrophil extracellular traps, suggesting that a combination of 
nanomaterial-based probes and advanced microscopy and spectroscopy techniques can be 
successfully applied to investigate biological processes. Furthermore, building up knowledge 
on mechanisms of NET release, networking with other immune cells, and degradation is the 
starting point to aspire to modulate and control those dynamics in order to exploit them for 
therapeutic purposes in autoimmune diseases or as microbicide weapons to be used in the 
antibiotic-resistant conditions. Overall, the present work has shed light on the role of NETs in 
both infectious and non-infectious scenarios.  
  53 
7 ACKNOWLEDGEMENTS 
 
The work presented in this thesis was performed at the Unit of Molecular Toxicology, Institute 
of Environmental Medicine, Karolinska Institutet, under the supervision of Prof. Bengt Fadeel, 
to whom I am deeply grateful for the continuous support, guidance and inspiring devotion to 
scientific research.  
I also would like to acknowledge my co-supervisors, Prof. Johan Frostegård and Dr. Malahat 
Mousavi, for their support and for stimulating discussions, and all the external collaborators 
that have been involved in the research projects herein described for their availability in sharing 
their precious expertise. 
Last, but not least, I am grateful to all the current and former colleagues in the unit and at the 
department for creating an enjoyable and stimulating work environment.  
This work was funded by the Swedish Research Council (Vetenskapsrådet) and the European 
Commission through the GRAPHENE Flagship Project.  
 54 
8 REFERENCES 
 
Achleitner M, Kleefisch M, Hennig A, Peschke K, Polikarpova A, Oertel R, Gabriel B, Schulze 
L, Lindeman D, Gerbaulet A, Fiebig U, Lee-Kirsch MA, Roers A, Behrendt R. 2017. Lack of 
Trex1 Causes Systemic Autoimmunity despite the Presence of Antiretroviral Drugs. J 
Immunol. 199: 2261-2269. 
Akdis M, Aab A, Altunbulakli C, Azkur K, Costa RA, Crameri R, Duan S, Eiwegger T, 
Eljaszewicz A, Ferstl R, Frei R, Garbani M, Globinska A, Hess L, Huitema C, Kubo T, 
Komlosi Z, Konieczna P, Kovacs N, Kucuksezer UC, Meyer N, Morita H, Olzhausen J, 
O'Mahony L, Pezer M, Prati M, Rebane A, Rhyner C, Rinaldi A, Sokolowska M, Stanic B, 
Sugita K, Treis A, van de Veen W, Wanke K, Wawrzyniak M, Wawrzyniak P, Wirz OF, 
Zakzuk JS, Akdis CA. 2016. Interleukins (from IL-1 to IL-38), interferons, transforming 
growth factor β, and TNF-α: Receptors, functions, and roles in diseases. J Allergy Clin 
Immunol. 138: 984-1010. 
Akhavan O, Ghaderi E, Hashemi E, Akbari E. 2015. Dose-dependent effects of nanoscale 
graphene oxide on reproduction capability of mammals. Carbon. 95: 309-317. 
Allen BL, Kotchey GP, Chen Y, Yanamala NV, Klein-Seetharaman J, Kagan VE, Star A. 2009. 
Mechanistic investigations of horseradish peroxidase-catalyzed degradation of single-walled 
carbon nanotubes. J Am Chem Soc. 131: 17194-17205. 
Al-Mayouf SM, Sunker A, Abdwani R, Abrawi SA, Almurshedi F, Alhashmi N, Al Sonbul A, 
Sewairi W, Qari A, Abdallah E, Al-Owain M, Al Motywee S, Al-Rayes H, Hashem M, Khalak 
H, Al-Jebali L, Alkuraya FS. 2011. Loss-of-function variant in DNASE1L3 causes a familial 
form of systemic lupus erythematosus. Nat Genet. 43: 1186-1188. 
Amulic B, Knackstedt SL, Abu Abed U, Deigendesch N, Harbort CJ, Caffrey BE, Brinkmann 
V, Heppner FL, Hinds PW, Zychlinsky A. 2017. Cell-Cycle Proteins Control Production of 
Neutrophil Extracellular Traps. Dev Cell. 43: 449-462. 
Arroyo A, Modriansky M, Serinkan FB, Bello RI, Matsura T, Jiang J, Tyurin VA, Tyurina YY, 
Fadeel B, Kagan VE. 2002. NADPH oxidase-dependent oxidation and externalization of 
phosphatidylserine during apoptosis in Me2SO-differentiated HL-60 cells. Role in phagocytic 
clearance. J Biol Chem. 277: 49965-49975. 
Awasthi D, Nagarkoti S, Kumar A, Dubey M, Singh AK, Pathak P, Chandra T, Barthwal MK, 
Dikshit M. 2016. Free Radic Biol Med. 93: 190-203. 
Bachiega TF, Dias-Melicio LA, Fernandes RK, de Almeida Balderramas H, Rodrigues DR, 
Ximenes VF, de Campos Soares ÂM. 2016. Participation of dectin-1 receptor on NETs release 
against Paracoccidioides brasiliensis: Role on extracellular killing. Immunobiology. 221: 
228-235. 
Barber GN. 2015. STING: infection, inflammation and cancer. Nat Rev Immunol. 15: 760-770. 
  55 
Barrientos L, Bignon A, Gueguen C, de Chaisemartin L, Gorges R, Sandré C, Mascarell L, 
Balabanian K, Kerdine-Römer S, Palladry M, Marin-Esteban V, Chollet-Martin S. 2014. 
Neutrophil extracellular traps downregulate lipopolysaccharide-induced activation of 
monocyte-derived dendritic cells. J Immunol. 193: 5689-5698. 
Bartneck M, Keul HA, Zwadlo-Klarwasser G, Groll J. 2010. Phagocytosis independent 
extracellular nanoparticle clearance by human immune cells. Nano Lett. 10: 59-63. 
Beams R, Cançado LG, Novotny L. 2015. Raman characterization of defects and dopants in 
graphene. J Phys Condens Matter. 27: 083002. 
Beiter K, Wartha F, Albiger B, Normark S, Zychlinsky A, Henriques-Normark B. 2006. An 
endonuclease allows Streptococcus pneumoniae to escape from neutrophil extracellular traps. 
Curr Biol. 16: 401-407. 
Beutler B. 2004. Innate immunity: an overview. Mol Immunol. 40: 845-859. 
Bhattacharya K, Andón FT, El-Sayed R, Fadeel B. 2013. Mechanisms of carbon nanotube-
induced toxicity: focus on pulmonary inflammation. Adv Drug Deliv Rev. 65: 2087-2097. 
Bhattacharya K, Kiliç G, Costa PM, Fadeel B. 2017. Cytotoxicity screening and cytokine 
profiling of nineteen nanomaterials enables hazard ranking and grouping based on 
inflammogenic potential. Nanotoxicology. 11: 809-826. 
Bhattacharya K, Mukherjee SP, Gallud A, Burkert SC, Bistarelli S, Bellucci S, Bottini M, Star 
A, Fadeel B. 2016. Biological interactions of carbon-based nanomaterials: From coronation to 
degradation. Nanomedicine. 12: 333-351. 
Bilski P, Belanger AG, Chignell CF. 2002. Photosensitized oxidation of 
2',7'-dichlorofluorescin: singlet oxygen does not contribute to the formation of fluorescent 
oxidation product 2',7'-dichlorofluorescein. Free Radic Biol Med. 33: 938-946. 
Bolles KM, Cheng F, Burk-Rafel J, Dubey M, Ratner DM. 2010. Imaging Analysis of 
Carbohydrate-Modified Surfaces Using ToF-SIMS and SPRi. Materials (Basel). 3. doi: 
10.3390/ma3073948. 
Borregaard N, Sehested M, Nielsen BS, Sengeløv H, Kjeldsen L. 1995. Biosynthesis of granule 
proteins in normal human bone marrow cells. Gelatinase is a marker of terminal neutrophil 
differentiation. Blood. 85: 812-817.  
Borregaard N. 2010. Neutrophils, from marrow to microbes. Immunity. 33: 657-670. 
Boulares H, Zoltoski A, Kandan S, Akbulut T, Yakovlev A, Oumouna M. 2006. Correlation 
between decreased sensitivity of the Daudi lymphoma cells to VP-16-induced apoptosis and 
deficiency in DNAS1L3 expression. Biochem Biophys Res Commun. 341: 653-662.  
Boztug K, Järvinen PM, Salzer E, Racek T, Mönch S, Garncarz W, Gertz EM, Schäffer AA, 
Antonopoulos A, Haslam SM, Schieck L, Puchałka J, Diestelhorst J, Appaswamy G, Lescoeur 
B, Giambruno R, Bigenzahn JW, Elling U, Pfeifer D, Conde CD, Albert MH, Welte K, Brandes 
G, Sherkat R, van der Werff Ten Bosch J, Rezaei N, Etzioni A, Bellanné-Chantelot C, Superti-
 56 
Furga G, Penninger JM, Bennett KL, von Blume J, Dell A, Donadieu J, Klein C. 2014. Nat 
Genet. 46: 1021-1027. 
Braian C, Hogea V, Stendahl O. 2013. Mycobacterium tuberculosis- induced neutrophil 
extracellular traps activate human macrophages. J Innate Immun. 5: 591-602. 
Branzk N, Lubojemska A, Hardison SE, Wang Q, Gutierrez MG, Brown GD, 
Papayannopoulos V. 2014. Neutrophils sense microbe size and selectively release neutrophil 
extracellular traps in response to large pathogens. Nat Immunol. 15: 1017-1025. 
Breloer M, Fleischer B. 2008. CD83 regulates lymphocyte maturation, activation and 
homeostasis. Trends Immunol. 29: 186-194. 
Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, 
Zychlinsky A. 2004. Neutrophil extracellular traps kill bacteria. Science. 303. 1532-1535. 
Brinkmann V, Zychlinsky A. 2012. Neutrophil extracellular traps: is immunity the second 
function of chromatin? J Cell Biol. 198: 773-783. 
Brison J, Benoit DS, Muramoto S, Robinson M, Stayton PS, Castner DG. 2011. ToF-SIMS 
imaging and depth profiling of HeLa cells treated with bromodeoxyuridine. Surf Interface 
Anal. 43: 354-357. 
Brubaker SW, Bonham KS, Zanoni I, Kagan JC. 2015. Innate immune pattern recognition: a 
cell biological perspective. Annu Rev Immunol. 33: 257-290. 
Byrd AS, O'Brien XM, Johnson CM, Lavigne LM, Reichner JS. 2013. An extracellular matrix-
based mechanism of rapid neutrophil extracellular trap formation in response to Candida 
albicans. J Immunol. 190: 4136-4148. 
Carlsson G, van't Hooft I, Melin M, Entesarian M, Laurencikas E, Nennesmo I, Trebińska A, 
Grzybowska E, Palmblad J, Dahl N, Nordenskjöld M, Fadeel B, Henter JI. 2008. Central 
nervous system involvement in severe congenital neutropenia: neurological and 
neuropsychological abnormalities associated with specific HAX1 mutations. J Intern Med. 
264: 388-400. 
Carmona-Rivera C, Carlucci PM, Moore E, Lingampalli N, Uchtenhagen H, James E, Liu Y, 
Bicker KL, Wahamaa H, Hoffmann V, Catrina AI, Thompson P, Buckner JH, Robinson WH, 
Fox DA, Kaplan MJ. 2017. Synovial fibroblast-neutrophil interactions promote pathogenic 
adaptive immunity in rheumatoid arthritis. Sci Immunol. 2: pii: eaag3358. 
Castillo MJ, Nakajima K, Zimmerman M, Powers JC. 1979. Sensitive substrates for human 
leukocyte and porcine pancreatic elastase: a study of the merits of various chromophoric and 
fluorogenic leaving groups in assays for serine proteases. Anal Biochem. 99: 53-64. 
Chamilos G, Gregorio J, Meller S, Lande R, Kontoyannis DP, Modlin RL, Gilliet M. 2012. 
Cytosolic sensing of extracellular self-DNA transported into monocytes by the antimicrobial 
peptide LL37. Blood. 120: 3699-3707. 
  57 
Chao JR, Parganas E, Boyd K, Hong CY, Opferman JT, Ihle JN. 2008. Hax1-mediated 
processing of HtrA2 by Parl allows survival of lymphocytes and neurons. Nature. 452: 98-102. 
Collins SJ, Gallo RC, Gallagher RE. 1977. Continuous growth and differentiation of human 
myeloid leukaemic cells in suspension culture. Nature. 270: 347-349. 
Commission Recommendation of 18 October 2011 on the definition of nanomaterial Text with 
EEA relevance.  OJ L 275, 20.10.2011, p. 38-40. 
Cools-Lartigue J, Spicer J, McDonald B, Gowing S, Chow S, Giannias B, Bourdeau F, Kubes 
P, Ferri L. 2013. Neutrophil extracellular traps sequester circulating tumor cells and promote 
metastasis. J Clin Invest. pii: 67484. 
Costello M, Pugh TJ, Fennel TJ, Stewart C, Lichtenstein L, Meldrim JC, Fostel JL, Friedrich 
DC, Perrin D, Dionne D, Kim S, Gabriel SB, Lander ES, Fisher S, Getz G. 2013. Discovery 
and characterization of artifactual mutations in deep coverage targeted capture sequencing data 
due to oxidative DNA damage during sample preparation. Nucleic Acids Res. 41: e67. 
Dale DC, Person RE, Bolyard AA, Aprikyan AG, Bos C, Bonilla MA, Boxer LA, Kannourakis 
G, Zeidler C, Welte K, Benson KF, Horwitz M. 2000. Mutations in the gene encoding 
neutrophil elastase in congenital and cyclic neutropenia. Blood. 96: 2317-2322. 
Donini M, Fontana S, Savoldi G, Vermi W, Tassone L, Gentili F, Zenaro E, Ferrari D, 
Notarangelo LD, Porta F, Facchetti F, Notarangelo LD, Dusi S, Badolato R. 2007. G-CSF 
treatment of severe congenital neutropenia reverses neutropenia but does not correct the 
underlying functional deficiency of the neutrophil in defending against microorganisms. Blood. 
109: 4716-4723. 
Douda DN, Khan MA, Grasemann H, Palaniyar N. 2015. SK3 channel and mitochondrial ROS 
mediate NADPH oxidase-independent NETosis induced by calcium influx. Proc Natl Acad Sci 
U S A. 112: 2817-2822. 
Duan G, Zhang Y, Luan B, Weber JK, Zhou RW, Yang Z, Zhao L, Xu J, Luo J, Zhou R. 2017. 
Graphene-Induced Pore Formation on Cell Membranes. Sci Rep. 7: 42767. 
Errami Y, Naura AS, Kim H, Ju J, Suzuki Y, El-Bahrawy AH, Ghonim MA, Hemeida RA, 
Mansy MS, Zhang J, Xu M, Smulson ME, Brim H, Boulares AH. 2013. Apoptotic DNA 
fragmentation may be a cooperative activity between caspase-activated deoxyribonuclease and 
the poly (ADP-ribose) polymerase-regulated DNAS1L3, an endoplasmic reticulum-localized 
endonuclease that translocates to the nucleus during apoptosis. J Biol Chem. 288: 3460-3468. 
Fadeel B, Fornara A, Toprak MS, Bhattacharya K. 2015. Keeping it real: The importance of 
material characterization in nanotoxicology. Biochem Biophys Res Commun. 18: 498-503. 
Fadeel B. 2012. Clear and present danger? Engineered nanoparticles and the immune system. 
Swiss Med Wkly. 142: w13609. 
Farrera C, Bhattacharya K, Lazzaretto B, Andón FT, Hultenby K, Kotchey GP, Star A, Fadeel 
B. 2014. Extracellular entrapment and degradation of single walled carbon nanotubes. 
Nanoscale. 6: 6974-6983. 
 58 
Farrera C, Fadeel B. 2013. Macrophage clearance of neutrophil extracellular traps is a silent 
process. J Immunol. 191: 2647-2656. 
Farrera C, Fadeel B. 2015. It takes two to tango: understanding the interactions between 
engineered nanomaterials and the immune system. Eur J Pharm Biopharm. 95: 3-12. 
Flach TL, Ng G, Hari A, Desrosiers MD, Zhang P, Ward SM, Seamone ME, Vilaysane A, 
Mucsi AD, Fong Y, Prenner E, Ling CC, Tschopp J, Muruve DA, Amrein MW, Shi Y. 2011. 
Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity. Nat  Med. 
17: 479-487. 
Fletcher JS, Lockyer NP, Vickerman JC. 2011. Developments in molecular SIMS depth 
profiling and 3D imaging of biological systems using polyatomic primary ions. Mass Spectrom 
Rev. 30: 142-174. 
Fuchs TA, Abed U, Goosmann C, Hurwitz R, Schulze I, Wahn V, Weinrauch Y, Brinkmann 
V, Zychlinsky A. 2007. Novel cell death program leads to neutrophil extracellular traps. J Cell 
Biol. 176: 231-241. 
Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DD Jr, Wrobleski SK, 
Wakefield TW, Hartwig JH, Wagner DD. 2010. Extracellular DNA traps promote thrombosis. 
Proc Natl Acad Sci U S A. 107: 15880-15885. 
Fye JM, Orebaugh CD, Coffin SR, Hollis T, Perrino FW. 2011. Dominant mutation of the 
TREX1 exonuclease gene in lupus and Aicardi-Goutieres syndrome. J Biol Chem. 286: 32373-
32382. 
Galli SJ, Borregaard N, Wynn TA. 2011. Phenotypic and functional plasticity of cells of innate 
immunity: macrophages, mast cells and neutrophils. Nat Immunol. 12: 1035-1044. 
Gallud A, Fadeel B. 2015. Keeping it small: towards a molecular definition of nanotoxicology. 
Eur J Nanomed. 7: 143-151. 
Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, 
Amelio I, Andrews DW, Annicchiarico-Petruzzelli M, Antonov AV, Arama E, Baehrecke EH, 
Barlev NA, Bazan NG, Bernassola F, Bertrand MJM, Bianchi K, Blagosklonny MV, Blomgren 
K, Borner C, Boya P, Brenner C, Campanella M, Candi E, Carmona-Gutierrez D, Cecconi F, 
Chan FK, Chandel NS, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Cohen GM, 
Conrad M, Cubillos-Ruiz JR, Czabotar PE, D'Angiolella V, Dawson TM, Dawson VL, De 
Laurenzi V, De Maria R, Debatin KM, DeBerardinis RJ, Deshmukh M, Di Daniele N, Di 
Virgilio F, Dixit VM, Dixon SJ, Duckett CS, Dynlacht BD, El-Deiry WS, Elrod JW, Fimia 
GM, Fulda S, García-Sáez AJ, Garg AD, Garrido C, Gavathiotis E, Golstein P, Gottlieb E, 
Green DR, Greene LA, Gronemeyer H, Gross A, Hajnoczky G, Hardwick JM, Harris IS, 
Hengartner MO, Hetz C, Ichijo H, Jäättelä M, Joseph B, Jost PJ, Juin PP, Kaiser WJ, Karin M, 
Kaufmann T, Kepp O, Kimchi A, Kitsis RN, Klionsky DJ, Knight RA, Kumar S, Lee SW, 
Lemasters JJ, Levine B, Linkermann A, Lipton SA, Lockshin RA, López-Otín C, Lowe SW, 
Luedde T, Lugli E, MacFarlane M, Madeo F, Malewicz M, Malorni W, Manic G, Marine JC, 
Martin SJ, Martinou JC, Medema JP, Mehlen P, Meier P, Melino S, Miao EA, Molkentin JD, 
Moll UM, Muñoz-Pinedo C, Nagata S, Nuñez G, Oberst A, Oren M, Overholtzer M, Pagano 
  59 
M, Panaretakis T, Pasparakis M, Penninger JM, Pereira DM, Pervaiz S, Peter ME, Piacentini 
M, Pinton P, Prehn JHM, Puthalakath H, Rabinovich GA, Rehm M, Rizzuto R, Rodrigues 
CMP, Rubinsztein DC, Rudel T, Ryan KM, Sayan E, Scorrano L, Shao F, Shi Y, Silke J, Simon 
HU, Sistigu A, Stockwell BR, Strasser A, Szabadkai G, Tait SWG, Tang D, Tavernarakis N, 
Thorburn A, Tsujimoto Y, Turk B, Vanden Berghe T, Vandenabeele P, Vander Heiden MG, 
Villunger A, Virgin HW, Vousden KH, Vucic D, Wagner EF, Walczak H, Wallach D, Wang 
Y, Wells JA, Wood W, Yuan J, Zakeri Z, Zhivotovsky B, Zitvogel L, Melino G, Kroemer G. 
2018. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee 
on Cell Death 2018. Cell Death Differ. 25: 486-541. 
Ganguly D, Chamilos G, Lande R, Gregorio J, Meller S, Facchinetti V, Homey B, Barrat FJ, 
Zal T, Gilliet M. 2009. Self-RNA-antimicrobial peptide complexes activate human dendritic 
cells through TLR7 and TLR8. J Exp Med. 206: 1983-1994. 
Gehrke N, Mertens C, Zillinger T, Wenzel J, Bald T, Zahn S, Tüting T, Hartmann G, Barchet 
W. 2013. Oxidative damage of DNA confers resistance to cytosolic nuclease TREX1 
degradation and potentiates STING-dependent immune sensing. Immunity. 39: 482-495. 
Girotti AW. 1998. Lipid hydroperoxide generation, turnover, and effector action in biological 
systems. J Lipid Res. 39: 1529-1542. 
Glaubach T, Minella AC, Corey SJ. 2014. Cellular stress pathways in pediatric bone marrow 
failure syndromes: many roads lead to neutropenia. Pediatr Res. 75: 189-195. 
Golpon HA, Fadok VA, Taraseviciene-Stewart L, Scerbavicius R, Sauer C, Welte T, Henson 
PM, Voelkel NF. 2004. Life after corpse engulfment: phagocytosis of apoptotic cells leads to 
VEGF secretion and cell growth. FASEB J. 8: 1716-1718. 
Gordon S, Plüddemann A. 2018. Macrophage Clearance of Apoptotic Cells: A Critical 
Assessment. Front Immunol. 9: 127. 
Gray RD, McCullagh BN, McCray PB. 2015. NETs and CF Lung Disease: Current Status and 
Future Prospects. Antibiotics (Basel). 4: 62-75. 
Grenda DS, Murakami M, Ghatak J, Xia J, Boxer LA, Dale D, Dinauer MC, Link DC. 2007. 
Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the 
unfolded protein response and cellular apoptosis. Blood. 110: 4179-4187. 
Grieves JL, Fye JM, Harvey S, Grayson JM, Hollis T, Perrino FW. 2015. Exonuclease TREX1 
degrades double-stranded DNA to prevent spontaneous lupus-like inflammatory disease. Proc 
Natl Acad Sci U S A. 112: 5117-5122. 
Griffith JW, Sokol CL, Luster AD. 2014. Chemokines and chemokine receptors: positioning 
cells for host defense and immunity. Annu Rev Immunol. 32: 659-702. 
Hajishengallis G, Reis ES, Mastellos DC, Ricklin D, Lambris JD. 2017. Novel mechanisms 
and functions of complement. Nat Immunol. 18: 1288-1298. 
 60 
Hakkim A, Fürnrohr BG, Amann K, Laube B, Abed UA, Brinkmann V, Herrmann M, Voll 
RE, Zychlinsky A. 2010. Impairment of neutrophil extracellular trap degradation is associated 
with lupus nephritis. Proc Natl Acad Sci U S A. 107: 9813-9818. 
Haniffa M, Collin M, Ginhoux F. 2013. Ontogeny and functional specialization of dendritic 
cells in human and mouse. Adv Immunol. 120: 1-49. 
Hansson M, Olsson I, Nauseef WM. 2006. Biosynthesis, processing, and sorting of human 
myeloperoxidase. Arch Biochem Biophys. 445: 214-224. 
Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. 1998. Impaired 
phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with 
systemic lupus erythematosus. Arthritis Rheum. 41: 1241-1250. 
Hochreiter-Hufford A, Ravichandran KS. 2013. Clearing the dead: apoptotic cell sensing, 
recognition, engulfment, and digestion. Cold Spring Harb Perspect Biol. 5: a008748. 
Horwitz M, Benson KF, Person RE, Aprikyan AG, Dale DC. 1999. Mutations in ELA2, 
encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat 
Genet. 23: 433-436. 
Hu Z, Murakami T, Tamura H, Reich J, Kuwahara-Arai K, Iba T, Tabe Y, Nagaoka I. 2017. 
Neutrophil extracellular traps induce IL-1β production by macrophages in combination with 
lipopolysaccharide. Int J Mol Med. 39: 549-558. 
Hwang TL, Aljuffali IA, Hung CF, Chen CH, Fang JY. 2015. The impact of cationic solid lipid 
nanoparticles on human neutrophil activation and formation of neutrophil extracellular traps 
(NETs). Chem Biol Interact. 235: 106-114. 
Italiani P, Boraschi D. 2014. From Monocytes to M1/M2 Macrophages: Phenotypical vs. 
Functional Differentiation. Front Immunol. 5: 514. 
Jiménez-Alcázar M, Rangaswamy C, Panda R, Bitterling J, Simsek YJ, Long AT, Bilyy R, 
Krenn V, Renné C, Renné T, Kluge S, Panzer U, Mizuta R, Mannherz HG, Kitamura D, 
Herrmann M, Napirei M, Fuchs TA. 2017. Host DNases prevent vascular occlusion by 
neutrophil extracellular traps. Science. 358: 1202-1206. 
Johnson CJ, Kernien JF, Hoyer AR, Nett JE. 2017. Mechanisms involved in the triggering of 
neutrophil extracellular traps (NETs) by Candida glabrata during planktonic and biofilm 
growth. Sci Rep. 7: 13065. 
Jorch SK, Kubes P. 2017. An emerging role for neutrophil extracellular traps in noninfectious 
disease. Nat Med. 23: 279-287. 
Kagan VE, Konduru NV, Feng W, Allen BL, Conroy J, Volkov Y, Vlasova II, Belikova NA, 
Yanamala N, Kapralov A, Tyurina YY, Shi J, Kisin ER, Murray AR, Franks J, Stolz D, Gou 
P, Klein-Seetharaman J, Fadeel B, Star A, Shvedova AA. 2010b. Carbon nanotubes degraded 
by neutrophil myeloperoxidase induce less pulmonary inflammation. Nat Nanotechnol. 
5: 354-359. 
  61 
Kagan VE, Kapralov AA, St Croix CM, Watkins SC, Kisin ER, Kotchey GP, Balasubramanian 
K, Vlasova II, Yu J, Kim K, Seo W, Mallampalli RK, Star A, Shvedova AA. 2014. Lung 
macrophages "digest" carbon nanotubes using a superoxide/peroxynitrite oxidative pathway. 
ACS Nano. 8: 5610-5621. 
Kagan VE, Shi J, Feng W, Shvedova AA, Fadeel B. 2010a. Fantastic voyage and opportunities 
of engineered nanomaterials: what are the potential risks of occupational exposures? J Occup 
Environ Med. 52: 943-946. 
Kahlenberg JM, Carmona-Rivera C, Smith CK, Kaplan MJ. 2013. Neutrophil extracellular 
trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus 
macrophages. J Immunol. 190: 1217-1226. 
Kahlenberg JM, Kaplan MJ. 2013. Little peptide, big effects: the role of LL-37 in inflammation 
and autoimmune disease. J Immunol. 191: 4895-4901. 
Kaul A, Gordon C, Crow MK, Touma Z, Urowitz MB, van Vollenhoven R, Ruiz-Irastorza G, 
Hughes G. 2016. Systemic lupus erythematosus. Nat Rev Dis Primers. 2: 16039. 
Kenny EF, Herzig A, Krüger R, Muth A, Mondal S, Thompson PR, Brinkmann V, Bernuth 
HV, Zychlinsky A. 2017. Diverse stimuli engage different neutrophil extracellular trap 
pathways. Elife. 6: pii: e24437. 
Kernien JF, Johnson CJ, Nett JE. 2017. Conserved Inhibition of Neutrophil Extracellular Trap 
Release by Clinical Candida albicans Biofilms. J Fungi (Basel). 3: pii: 49. 
Kessenbrock K, Krumbholz M, Schönermarck U, Back W, Gross WL, Werb Z, Gröne HJ, 
Brinkmann V, Jenne DE. 2009. Netting neutrophils in autoimmune small-vessel vasculitis. Nat 
Med. 15: 623-625. 
Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, Gizinski A, Yalavarthi S, Knight JS, 
Friday S, Li S, Patel RM, Subramanian V, Thompson P, Chen P, Fox DA, Pennathur S, Kaplan 
MJ. 2013. NETs are a source of citrullinated autoantigens and stimulate inflammatory 
responses in rheumatoid arthritis. Sci Transl Med. 5: 178ra40. 
Kim TK, Eberwine JH. 2010. Mammalian cell transfection: the present and the future. Anal 
Bioanal Chem. 397: 3173-3178. 
Klein C, Grudzien M, Appaswamy G, Germeshausen M, Sandrock I, Schäffer AA, Rathinam 
C, Boztug K, Schwinzer B, Rezaei N, Bohn G, Melin M, Carlsson G, Fadeel B, Dahl N, 
Palmblad J, Henter JI, Zeidler C, Grimbacher B, Welte K. 2007. HAX1 deficiency causes 
autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet. 39: 86-92. 
Kolaczkowska E, Jenne CN, Surewaard BG, Thanabalasuriar A, Lee WY, Sanz MJ, Mowen 
K, Opdenakker G, Kubes P. 2015. Molecular mechanisms of NET formation and degradation 
revealed by intravital imaging in the liver vasculature. Nat Commun. 6: 6673. 
Kolosnjaj-Tabi J, Just J, Hartman KB, Laoudi Y, Boudjemaa S, Alloyeau D, Szwarc H, Wilson 
LJ, Moussa F. 2015. Anthropogenic Carbon Nanotubes Found in the Airways of Parisian 
Children. EBioMedicine. 2: 1697-1704. 
 62 
Kono H, Onda A, Yanagida T. 2014. Molecular determinants of sterile inflammation. Curr  
Opin Immunol. 26: 147-156. 
Kostmann R. 1956. Infantile genetic agranulocytosis; agranulocytosis infantilis hereditaria. 
Acta Paediatr Suppl. 45: 1-78. 
Lancaster MV, Fields RD. 1996. Antibiotic and cytotoxic drug susceptibility assays using 
resazurin and poising agents. Patent no. US5501959. 
Lande R, Ganguly D, Facchinetti V, Frasca L, Conrad C, Gregorio J, Meller S, Chamilos G, 
Sebasigari R, Riccieri V, Bassett R, Amuro H, Fukuhara S, Ito T, Liu YJ, Gilliet M. 2011. 
Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in 
systemic lupus erythematosus. Sci Transl Med. 3: 73ra19. 
Lanier LL, O'Fallon S, Somoza C, Phillips JH, Linsley PS, Okumura K, Ito D, Azuma M. 1995. 
CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, 
cytokine production, and generation of CTL. J Immunol. 154: 97-105. 
Lee S, Cooley L. 2007. Jagunal is required for reorganizing the endoplasmic reticulum during 
Drosophila oogenesis. J Cell Biol. 176: 941-952. 
Lee-Kirsch MA, Gong M, Chowdhury D, Senenko L, Engel K, Lee YA, de Silva U, Bailey 
SL, Witte T, Vyse TJ, Kere J, Pfeiffer C, Harvey S, Wong A, Koskenmies S, Hummel O, 
Rohde K, Schmidt RE, Dominiczak AF, Gahr M, Hollis T, Perrino FW, Lieberman J, 
Hübner N. 2007. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are 
associated with systemic lupus erythematosus. Nat Genet. 39: 1065-1067. 
Leffler J, Martin M, Gullstrand B, Tydén H, Lood C, Truedsson L, Bengtsson AA, Blom AM. 
2012. Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus 
activate complement exacerbating the disease. J Immunol. 188: 3522-3531. 
Lehrer RI, Cline MJ. 1969. Leukocyte myeloperoxidase deficiency and disseminated 
candidiasis: the role of myeloperoxidase in resistance to Candida infection. J Clin Invest. 48: 
1478-1488. 
Lei H, Mi L, Zhou X, Chen J, Hu J, Guo S, Zhang Y. 2011. Adsorption of double-stranded 
DNA to graphene oxide preventing enzymatic digestion. Nanoscale. 3: 3888-3892. 
Leppkes M, Maueröder C, Hirth S, Nowecki S, Günther C, Billmeier U, Paulus S, Biermann 
M, Munoz LE, Hoffmann M, Wildner D, Croxford AL, Waisman A, Mowen K, Jenne DE, 
Krenn V, Mayerle J, Lerch MM, Schett G, Wirtz S, Neurath MF, Herrmann M, Becker C. 
2016. Externalized decondensed neutrophil chromatin occludes pancreatic ducts and drives 
pancreatitis. Nat Commun. 7: 10973. 
Lingwood D, Simons K. 2010. Lipid rafts as a membrane-organizing principle. Science. 
327: 46-50. 
Lisnevskaia L, Murphy G, Isenberg D. 2014. Systemic lupus erythematosus. Lancet. 
384: 1878-1888. 
  63 
Liz R, Simard JC, Leonardi LB, Girard D. 2015. Silver nanoparticles rapidly induce atypical 
human neutrophil cell death by a process involving inflammatory caspases and reactive oxygen 
species and induce neutrophil extracellular traps release upon cell adhesion. Int 
Immunopharmacol. 28: 616-625. 
Lundin A. 2000. Use of firefly luciferase in ATP-related assays of biomass, enzymes, and 
metabolites. Methods Enzymol. 305: 346-370. 
Ma J, Liu R, Wang X, Liu Q, Chen Y, Valle RP, Zuo YY, Xia T, Liu S. 2015. Crucial Role of 
Lateral Size for Graphene Oxide in Activating Macrophages and Stimulating Pro-
inflammatory Responses in Cells and Animals. ACS Nano. 9: 10498-10515. 
Magdolenova Z, Collins A, Kumar A, Dhawan A, Stone V, Dusinska M. 2014. Mechanisms 
of genotoxicity. A review of in vitro and in vivo studies with engineered nanoparticles. 
Nanotoxicology. 8: 233-278. 
Mahlapuu M, Håkansson J, Ringstad L, Björn C. 2016. Antimicrobial peptides: an emerging 
category of therapeutic agents. Front Cell Infect Microbiol. 6: 194. 
Martinelli S, Urosevic M, Daryadel A, Oberholzer PA, Baumann C, Fey MF, Dummer R, 
Simon HU, Yousefi S. 2004. Induction of genes mediating interferon-dependent extracellular 
trap formation during neutrophil differentiation. J Biol Chem. 279: 44123-44132. 
Massey JB, Pownall HJ. 2005. Role of oxysterol structure on the microdomain-induced 
microsolubilization of phospholipid membranes by apolipoprotein A-I. Biochemistry. 44: 
14376-14384. 
Mayadas TN, Cullere X, Lowell CA. 2014. The multifaceted functions of neutrophils. Annu 
Rev Pathol. 9: 181-218. 
Maynard AD. 2011. Don’t define nanomaterials. Nature. 475: 31. 
Medzhitov R. 2008. Origin and physiological roles of inflammation. Nature. 454: 428-435. 
Menegazzo L, Ciciliot S, Poncina N, Mazzucato M, Persano M, Bonora B, Albiero M, Vigili 
de Kreutzenberg S, Avogaro A, Fadini GP. 2015. NETosis is induced by high glucose and 
associated with type 2 diabetes. Acta Diabetol. 52: 497-503. 
Mestass J, Huges CC. 2004. Of mice and not men: differences between mouse and human 
immunology. J Immunol. 172: 2731-2738. 
Metzler KD, Fuchs TA, Nauseef WM, Reumaux D, Roesler J, Schulze I, Wahn V, 
Papayannopoulos V, Zychlinsky A. 2011. Myeloperoxidase is required for neutrophil 
extracellular trap formation: implications for innate immunity. Blood. 117: 953-959. 
Metzler KD, Goosmann C, Lubojemska A, Zychlinsky A, Papayannopoulos V. 2014. A 
myeloperoxidase-containing complex regulates neutrophil elastase release and actin dynamics 
during NETosis. Cell Rep. 8: 883-896. 
 64 
Mizuta R, Araki S, Furukawa M, Furukawa Y, Ebara S, Shiokawa D, Hayashi K, Tanuma S, 
Kitamura D. 2013. DNase γ is the effector endonuclease for internucleosomal DNA 
fragmentation in necrosis. PLoS One. 8: e80223. 
Mócsai A. 2013. Diverse novel functions of neutrophils in immunity, inflammation, and 
beyond. J Exp Med. 210: 1283-1299. 
Monopoli MP, Aberg C, Salvati A, Dawson KA. 2012. Biomolecular coronas provide the 
biological identity of nanosized materials. Nat Nanotechnol. 7: 779-786. 
Mukherjee SP, Bondarenko O, Kohonen P, Andón FT, Brzicová T, Gessner I, Mathur S, 
Bottini M, Calligari P, Stella L, Kisin E, Shvedova A, Autio R, Salminen-Mankonen H, 
Lahesmaa R, Fadeel B. 2018b. Macrophage sensing of single-walled carbon nanotubes via 
Toll-like receptors. Sci Rep. 8: 1115. 
Mukherjee SP, Bottini M, Fadeel B. 2017. Graphene and the Immune System: A Romance of 
Many Dimensions. 2017. Front Immunol. 8: 673. 
Mukherjee SP, Kostarelos K, Fadeel B. 2018a. Cytokine Profiling of Primary Human 
Macrophages Exposed to Endotoxin-Free Graphene Oxide: Size-Independent NLRP3 
Inflammasome Activation. Adv Healthc Mater. 7: 1700815. 
Mukherjee SP, Lozano N, Kucki M, Del Rio-Castillo AE, Newman L, Vázquez E, Kostarelos 
K, Wick P, Fadeel B. 2016. Detection of endotoxin contamination of graphene based materials 
using the TNF-α expression test and guidelines for endotoxin-free graphene oxide production. 
PLoS One. 11: e0166816. 
Muñoz LE, Bilyy R, Biermann MH, Kienhöfer D, Maueröder C, Hahn J, Brauner JM, Weidner 
D, Chen J, Scharin-Mehlmann M, Janko C, Friedrich RP, Mielenz D, Dumych T, Lootsik MD, 
Schauer C, Schett G, Hoffmann M, Zhao Y, Herrmann M. 2016. Nanoparticles size-
dependently initiate self-limiting NETosis-driven inflammation. Proc Natl Acad Sci U S A. 
113: E5856-E5865. 
Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, Gordon S, Hamilton JA, 
Ivashkiv LB, Lawrence T, Locati M, Mantovani A, Martinez FO, Mege JL, Mosser DM, Natoli 
G, Saeij JP, Schultze JL, Shirey KA, Sica A, Suttles J, Udalova I, van Ginderachter JA, Vogel 
SN, Wynn TA. 2014. Macrophage activation and polarization: nomenclature and experimental 
guidelines. Immunity. 41: 14-20. 
Nakazawa D, Shida H, Kusunoki Y, Miyoshi A, Nishio S, Tomaru U, Atsumi T, Ishizu A. 
2015. The responses of macrophages in interaction with neutrophils that undergo NETosis. J 
Autoimmun. 67: 19-28. 
Napirei M, Wulf S, Eulitz D, Mannherz HG, Kloeckl T. 2005. Comparative characterization 
of rat deoxyribonuclease 1 (Dnase1) and murine deoxyribonuclease 1-like 3 (Dnase1l3). 
Biochem J. 389: 355-364. 
Nathan C. 2006. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol. 
6: 173-182. 
  65 
Nayak TR, Andersen H, Makam VS, Khaw C, Bae S, Xu X, Ee PL, Ahn JH, Hong BH, Pastorin 
G, Özyilmaz B. 2011. Graphene for controlled and accelerated osteogenic differentiation of 
human mesenchymal stem cells. ACS Nano. 5: 4670-4678. 
Nel A, Xia T, Mädler L, Li N. 2006. Toxic potential of materials at the nanolevel. Science. 
311: 622-627. 
Netea MG, Balkwill F, Chonchol M, Cominelli F, Donath MY, Giamarellos-Bourboulis EJ, 
Golenbock D, Gresnigt MS, Heneka MT, Hoffman HM, Hotchkiss R, Joosten LAB, Kastner 
DL, Korte M, Latz E, Libby P, Mandrup-Poulsen T, Mantovani A, Mills KHG, Nowak KL, 
O'Neill LA, Pickkers P, van der Poll T, Ridker PM, Schalkwijk J, Schwartz DA, Siegmund B, 
Steer CJ, Tilg H, van der Meer JWM, van de Veerdonk FL, Dinarello CA. 2017. A guiding 
map for inflammation. Nat Immunol. 18: 826-831. 
Neumann A, Brogden G, Jerjomiceva N, Brodesser S, Naim HY, von Köckritz-Blockwede M. 
2014a. Lipid alterations in human blood-derived neutrophils lead to formation of neutrophil 
extracellular traps. Eur J Cell Biol. 93: 347-354. 
Neumann A, Völlger L, Berends ET, Molhoek EM, Stapels DA, Midon M, Friães A, Pingoud 
A, Rooijakkers SH, Gallo RL, Mörgelin M, Nizet V, Naim HY, von Köckritz-Blickwede M. 
2014b. Novel role of the antimicrobial peptide LL-37 in the protection of neutrophil 
extracellular traps against degradation by bacterial nucleases. J Innate Immun. 6: 860-868. 
Ng G, Sharma K, Ward SM, Desrosiers MD, Stephens LA, Schoel WM, Li T, Lowell CA, 
Ling CC, Amrein MW, Shi Y. 2008. Receptor-independent, direct membrane binding leads to 
cell-surface lipid sorting and Syk kinase activation in dendritic cells. Immunity. 29: 807-818. 
Nordenfelt P, Tapper H. 2011. Phagosome dynamics during phagocytosis by neutrophils. J 
Leukoc Biol. 90: 271-284. 
Nygren H, Malmberg P. 2007. High resolution imaging by organic secondary ion mass 
spectrometry. Trends Biotechnol. 25: 499-504. 
Ortega-Gómez A, Perretti M, Soehnlein O. 2013. Resolution of inflammation: an integrated 
view. EMBO Mol Med. 5: 661-674. 
Papadaki G, Kambas K, Choulaki C, Vlachou K, Drakos E, Bertsias G, Ritis K, Boumpas DT, 
Thompson PT, Verginis P, Sidropoulos P. 2016. Neutrophil extracellular traps exacerbate Th1-
mediated autoimmune responses in rheumatoid arthritis by promoting DC maturation. Eur J 
Immunol. 46: 2542-2554. 
Papayannopoulos V, Metzler KD, Hakkim A, Zychlinsky A. 2010. Neutrophil elastase and 
myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol. 191: 
677-691. 
Papayannopoulos V, Zychlinsky A. 2009. NETs: a new strategy for using old weapons. Trends 
Immunol. 30: 513-521. 
Papayannopoulos V. 2017. Neutrophil extracellular traps in immunity and disease. Nat Rev 
Immunol. 18: 134-147. 
 66 
Park SY, Park J, Sim SH, Sung MG, Kim KS, Hong BH, Hong S. 2011. Enhanced 
differentiation of human neural stem cells into neurons on graphene. Adv Mater. 23: 
H263-H267. 
Parker H, Albrett AM, Kettle AJ, Winterbourn CC. 2012a. Myeloperoxidase associated with 
neutrophil extracellular traps is active and mediates bacterial killing in the presence of 
hydrogen peroxide. J Leukoc Biol. 91: 369-376. 
Parker H, Dragunow M, Hampton MB, Kettle AJ, Winterbourn CC. 2012b. Requirements for 
NADPH oxidase and myeloperoxidase in neutrophil extracellular trap formation differ 
depending on the stimulus. J Leukoc Biol. 92: 841-849. 
Pilsczek FH, Salina D, Poon KK, Fahey C, Yipp BG, Sibley CD, Robbins SM, Green FH, 
Surette MG, Sugai M, Bowden MG, Hussain M, Zhang K, Kubes P. 2010. A novel mechanism 
of rapid nuclear neutrophil extracellular trap formation in response to Staphylococcus aureus. 
J Immunol.185: 7413-7415. 
Poon IK, Lucas CD, Rossi AG, Ravichandran KS. 2014. Apoptotic cell clearance: basic 
biology and therapeutic potential. Nat Rev Immunol. 14: 166-180. 
Potter H, Heller R. 2018. Transfection by electroporation. Curr Protoc Mol Biol. 121: 9.3.1-
9.3.13.  
Rahman A, Isenberg DA. 2008. Systemic lupus erythematosus. N Engl J Med. 358: 929-939. 
Reddel, RR, Yang K, Rhim JS, Brash D, Su RT, Lechner JF, Gerwin BI, Harris CC, Amstad 
P. 1989. Immortalized human bronchial epitherial mesothelial cell lines. Patent no. 
US4885238A. 
Retamal Marin RR, Babick F, Hillemann L. 2017. Zeta potential measurements for non-
spherical colloidal particles – Practical issues of characterization of interfacial properties of 
nanoparticles. Colloid Surface A. 532: 516-521. 
Ricklin D, Hajishengallis G, Yang K, Lambris JD. 2010. Complement: a key system for 
immune surveillance and homeostasis. Nat Immunol. 11: 785-797. 
Robinson MA, Graham DJ, Castner DG. 2012. ToF-SIMS depth profiling of cells: 
z-correction, 3D imaging, and sputter rate of individual NIH/3T3 fibroblasts. Anal Chem. 
84: 4880-4885. 
Rohrbach AS, Slade DJ, Thompson PR, Mowen KA. 2012. Activation of PAD4 in NET 
formation. Front. Immunol. 3: 360. 
Russier J, Treossi E, Scarsi A, Perrozzi F, Dumortier H, Ottaviano L, Meneghetti M, Palermo 
V, Bianco A. 2013. Evidencing the mask effect of graphene oxide: a comparative study on 
primary human and murine phagocytic cells. Nanoscale. 5: 11234-11247. 
Scapini P, Cassatella MA. 2014. Social networking of human neutrophils within the immune 
system. Blood. 124: 710-719. 
  67 
Scapini P, Marini O, Tecchio C, Cassatella MA. 2016. Human neutrophils in the saga of 
cellular heterogeneity: insights and open questions. Immunol Rev. 273. 48-60. 
Schauer C, Janko C, Munoz LE, Zhao Y, Kienhöfer D, Frey B, Lell M, Manger B, Rech J, 
Naschberger E, Holmdahl R, Krenn V, Harrer T, Jeremic I, Bilyy R, Schett G, Hoffmann M, 
Herrmann M. 2014. Aggregated neutrophil extracellular traps limit inflammation by degrading 
cytokines and chemokines. Nat Med. 20: 511-517. 
Shiokawa D, Shika Y, Tanuma S. 2003. Identification of two functional nuclear localization 
signals in DNase gamma and their roles in its apoptotic DNase activity. Biochem J. 376: 
377-381. 
Shvedova AA, Kagan VE, Fadeel B. 2010. Close encounters of the small kind: adverse effects 
of man-made materials interfacing with the nano-cosmos of biological systems. Annu Rev 
Pharmacol Toxicol. 50: 63-88. 
Sisirak V, Sally B, D'Agati V, Martinez-Ortiz W, Özçakar ZB, David J, Rashidfarrokhi A, 
Yeste A, Panea C, Chida AS, Bogunovic M, Ivanov II, Quintana FJ, Sanz I, Elkon KB, Tekin 
M, Yalçınkaya F, Cardozo TJ, Clancy RM, Buyon JP, Reizis B. 2016. Digestion of chromatin 
in apoptotic cell microparticles prevents autoimmunity. Cell. 166: 88-101. 
Smolen JS, Aletaha D, McInnes IB. 2016. Rheumatoid arthritis. Lancet. 388: 2023-2038. 
Soehnlein O, Steffens S, Hidalgo A, Weber C. 2017. Neutrophils as protagonists and targets in 
chronic inflammation. Nat Rev Immunol. 17: 248-261. 
Steinberg BE, Grinstein S. 2007. Unconventional roles of the NADPH oxidase: signaling, ion 
homeostasis, and cell death. Sci STKE. 2007: pe11. 
Stetson DB, Ko JS, Heidmann T, Medzhitov R. 2008. Trex1 prevents cell-intrinsic initiation 
of autoimmunity. Cell. 134: 587-598. 
Sugimoto MA, Sousa LP, Pinho V, Perretti M, Teixeira MM. 2016. Resolution of 
inflammation: what controls its onset? Front Immunol. 7: 160. 
Sun C, Wakefield DL, Han Y, Muller DA, Holowka DA, Baird BA, Dichtel WR. 2016. 
Graphene Oxide Nanosheets Stimulate Ruffling and Shedding of Mammalian Cell Plasma 
Membranes. Chem. 1: 273-286. 
Takeuchi O, Akira S. 2010. Pattern recognition receptors and inflammation. Cell. 140: 
805-820. 
Thammavongsa V, Missiakas DM, Schneewind O. 2013. Staphylococcus aureus degrades 
neutrophil extracellular traps to promote immune cell death. Science. 342: 863-866. 
Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas 
E, Ryu JC, Sasaki YF. 2000. Single cell gel/comet assay: guidelines for in vitro and in vivo 
genetic toxicology testing. Environ Mol Mutagen. 35: 206-221. 
 68 
Tonelli FM, Goulart VA, Gomes KN, Ladeira MS, Santos AK, Lorençon E, Ladeira LO, 
Resende RR. 2015. Graphene-based nanomaterials: biological and medical applications and 
toxicity. Nanomedicine (Lond). 10: 2423-2450. 
Tran CL, Tantra R, Donaldson K, Stone V, Hankin SM, Ross B, Aitken RJ, Jones AD. 2011. 
A hypothetical model for predicting the toxicity of high aspect ratio nanoparticles (HARN). 
J Nanopart Res. 13: 6683-6698. 
Turvey SE, Broide DH. 2010. Innate immunity. J Allergy Clin Immunol. 125: S24-S32. 
Urban CF, Ermert D, Schmid M, Abu-Abed U, Goosmann C, Nacken W, Brinkmann V, 
Jungblut PR, Zychlinsky A. 2009. Neutrophil extracellular traps contain calprotectin, a 
cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog. 5: 
e1000639. 
Urban CF, Reichard U, Brinkmann V, Zychlinsky A. 2006. Neutrophil extracellular traps 
capture and kill Candida albicans yeast and hyphal forms. Cell Microbiol. 8 :668-676. 
Villanueva E, Yalavarthi S, Berthier CC, Hodgin JB, Khandpur R, Lin AM, Rubin CJ, Zhao 
W, Olsen SH, Klinker M, Shealy D, Denny MF, Plumas J, Chaperot L, Kretzler M, Bruce AT, 
Kaplan MJ. 2011. Netting neutrophils induce endothelial damage, infiltrate tissues, and expose 
immunostimulatory molecules in systemic lupus erythematosus. J Immunol. 187: 538-552. 
von Köckritz-Blickwede M, Chow OA, Nizet V. 2009. Fetal calf serum contains heat-stable 
nucleases that degrade neutrophil extracellular traps. Blood. 114: 5245-5246. 
Vong L, Sherman PM, Glogauer M. 2013. Quantification and visualization of neutrophil 
extracellular traps (NETs) from murine bone marrow-derived neutrophils. Methods Mol Biol. 
1031: 41-50. 
Warnatsch A, Ioannou M, Wang Q, Papayannopoulos V. 2015. Neutrophil extracellular traps 
license macrophages for cytokine production in atherosclerosis. Science. 349: 316-320. 
Wick P, Louw-Gaume AE, Kucki M, Krug HF, Kostarelos K, Fadeel B, Dawson KA, Salvati 
A, Vázquez E, Ballerini L, Tretiach M, Benfenati F, Flahaut E, Gauthier L, Prato M, Bianco 
A. 2014. Classification framework for graphene-based materials. Angew Chem Int Ed Engl. 
53: 7714-7718. 
Wirnsberger G, Zwolanek F, Stadlmann J, Tortola L, Liu SW, Perlot T, Järvinen P, Dürnberger 
G, Kozieradzki I, Sarao R, De Martino A, Boztug K, Mechtler K, Kuchler K, Klein C, Elling 
U, Penninger JM. 2014. Jagunal homolog 1 is a critical regulator of neutrophil function in 
fungal host defense. Nat Genet. 46:1028-1033. 
Wong SL, Demers M, Martinod K, Gallant M, Wang Y, Goldfine AB, Kahn CR, Wagner DD. 
2015. Diabetes primes neutrophils to undergo NETosis, which impairs wound healing. Nat 
Med. 21: 815-819. 
Yan N, Regalado-Magdos AD, Stiggelbout B, Lee-Kirsch MA, Lieberman J. 2010. The 
cytosolic exonuclease TREX1 inhibits the innate immune response to human 
immunodeficiency virus type 1. Nat Immunol. 11: 1005-1013. 
  69 
Yang Y, Asiri AM, Tang Z, Du D, Lin Y. 2013. Graphene based materials for biomedical 
applications. Mater Today. 16: 365-373. 
Yasutomo K, Horiuchi T, Kagami S, Tsukamoto H, Hashimura C, Urushihara M, Kuroda Y. 
2001. Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet. 28: 
313-314. 
Yipp BG, Kubes P. 2013. NETosis: how vital is it? Blood. 122: 2784-2794. 
Yipp BG, Petri B, Salina D, Jenne CN, Scott BN, Zbytnuik LD, Pittman K, Asaduzzaman M, 
Wu K, Meijndert HC, Malawista SE, de Boisfleury Chevance A, Zhang K, Conly J, Kubes P. 
2012. Infection-induced NETosis is a dynamic process involving neutrophil multitasking in 
vivo. Nat Med. 18: 1386-1393. 
Yousefi S, Mihalache C, Kozlowski E, Schmid I, Simon HU. 2009. Viable neutrophils release 
mitochondrial DNA to form neutrophil extracellular traps. Cell Death Differ. 16: 1438-1444. 
 
